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Abstract 
Basal cell carcinoma (BCC), a keratinocyte cancer, is the most common human neoplasm 
worldwide. Although rarely metastatic, BCC is associated with high morbidity rates with 
globally rising incidence rates. Accompanying the increase in newly diagnosed cases, the 
societal cost for BCC treatment in Canada is also expected to inflate, exceeding over $900 
million/year by 2031. Chronic UVB exposure has been identified as the primary carcinogen 
that causes activating mutations in the hedgehog signaling pathway. However, there are no 
effective preventative methods against BCC, since meta-analyses report sunscreen 
application does not reduce BCC in compliant patients. The native high molecular-weight 
hyaluronan (HMW-HA) was recently reported to confer tumor resistance to carcinogens 
including UVB in naked mole-rats (Heterocephalus glaber). We therefore prepared 
phosphatidylethanolamine-linked HMW-HA polymers (HA-PE) for topical application in 
UVB-induced, BCC susceptible Ptch+/LacZ/Hr-/- mice. HA-PE formed detectable HA coats 
around epidermal and hair follicle keratinocytes, and prevented histologically-detectable 
keratinocyte tumor formation, verified by reduced Ptch1 promoter activity indicating 
oncogenic hedgehog pathway shutdown. Further evidence of signaling inactivation by HA-
PE includes strong suppression of the expression of hedgehog pathway gene targets in both 
the epidermis and hair follicles. Surprisingly, HA-PE did not prevent UVB/ROS-induced 
DNA damage. However, HA-PE promoted quiescence in the hair follicle bulge and 
selective apoptosis of K15+ stem cells that are BCC initiating in the Ptch1+/LacZ/Hr-/- 
susceptibility model.  Consistent with this finding, the K15+ stem cells population 
decreased from hair follicles between 4-26 weeks of treatment. These results provide 
evidence of a novel mechanism for HA-mediated tumor resistance and implicate HA-PE 
as a promising BCC prophylactic. This knowledge will also provide a model for probing 
the interplay between the microenvironment and oncogenic mutations that permit or 
restrain tumor initiation.  
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Chapter 1  
1 Introduction 
1.1 Basal cell carcinoma 
Basal cell carcinoma (BCCs) are locally aggressive keratinocyte tumors with a recurrence 
rate of 50% in 5 years following diagnosis. BCC is the most common form of neoplasm in 
adults 1,2,3, accounting for 70% of all keratinocyte tumors and 90% of all malignant skin 
diseases. Chronic exposure to ultraviolet (UV) radiation has been identified as the primary 
risk factor for BCC 4. Historically, BCC occurs more frequently in fair-skinned populations 
and in males due to increased sun-exposure in workplaces5–9. However, this regional and 
sex difference is decreasing due to steady depletion of the protective ozone layer and 
enhanced UV exposure in all populations 10–12. Although BCC was originally considered 
as a malignancy of the older population (>65 years of age), epidemiological studies report 
a dramatic increase in BCC incidence in younger populations during the last decade due to 
tanning bed usage 5–7,12–14. BCC rarely metastasizes, but is locally aggressive and causes 
dermal tissue destruction, thus resulting in high morbidity rates 15. Moreover, a history of 
non-melanoma skin cancer is associated with increased risk of developing secondary 
tumors prone to metastasis, such as breast, prostate and colon cancers16-18. Currently, 
societal cost for BCC treatment and related expenses in Canada is approximately $34.6 
million (www.iwh.on.ca) and is expected to exceed over $900 million by 2031 (Canadian 
Partnership Against Cancer, 2010).  
Common treatments of BCC include non-specific surgical removal of tumors, application 
of oncogenic pathway inhibitors, and radiotherapy 19,20. However, surgical excisions often 
contribute to patient morbidity as they are visibly scarring, while inhibitor treatment is 
associated with increased risk of developing secondary low-grade keratinocyte tumors20,21. 
Moreover, multiple tumor recurrences are common following surgical excisions and 
targeted therapy (up to 7% within 5 years)22–24, contributing to the accumulation of 
healthcare cost and deterioration of quality of life. In addition, radiotherapy is commonly 
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recommended as a palliative treatment in elderly patients 25, and is associated with higher 
cost and recurrence (85% within 3 years) 26,27.   
1.1.1 Molecular mechanisms of BCC tumorigenesis  
Advancement in the past decade has identified aberrant activation of the sonic hedgehog 
signaling as the primary cause of BCC pathogenesis 28,29,30-32. Hedgehog signaling plays a 
pivotal role in embryogenesis through orchestrating cell-cell communication of the 
epidermis and neural patterning31. During morphogenesis, sonic hedgehog signaling 
promotes proliferation, differentiation, and vascularization33, all of which are employed by 
tumor cells for growth and metastasis. In post-natal skin, hedgehog signaling promotes 
active growth of hair (anagen) and is required for hair follicle-resident multipotent stem 
cell proliferation29,34. The pathway is activated when the extracellular ligand sonic 
hedgehog (SHH) binds and inhibits the transmembrane receptor Patched1 (PTCH1), 
triggering rapid endocytosis of the PTCH-SHH complex33,35. The internalization of PTCH1 
releases its suppression of Smoothened (SMO), cumulating in the activation and nuclear 
translocation of the GLI family of transcriptional factors (Figure 1). Specifically, GLI2 and 
GLI3 accumulate in the nucleus and induce target gene expression in the presence of SHH. 
In contrast, GLI1 expression can only be induced by activated GLI2/3 and is dependent on 
active sonic hedgehog signaling. Thus, GLI1 is a reliable molecular marker of hedgehog 
activation, and its overexpression is characteristic of sporadic BCC29. Other target genes 
of the sonic hedgehog pathway include Ptch1, a negative regulator that dampens the signal 
transduction of this pathway, and various regulators of cell cycle and apoptosis, such as 
Bcl-2 and Ccnd1/2. 29,36. Since PTCH1 and GLI1 are both regulators and target genes of 
hedgehog signaling, they are often used as markers to examine hedgehog signaling 
activation37–39.  
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Figure 1: Sonic hedgehog signaling pathway. When the sonic hedgehog ligand (SHH) is 
absent, the pathway is inactivated. Tumor-suppressor Patched 1 (PTCH1) inhibits 
downstream Smoothened (SMO). However, PTCH1 is inactivated with SHH binding, 
allowing SMO to activate the transcriptional factor family GLI to induce target gene 
expression. GLI1 expression relies on GLI2/3 activation, therefore its expression level is 
often used as an indicator of the overall signaling activity in the sonic hedgehog pathway.  
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Pathogenic activation of the sonic hedgehog pathway can occur through sustaining 
inactivation mutations in Ptch1, thus abolishing its inhibition of SMO. Genetic studies 
report over 90% of sporadic BCC patients sustain Ptch1 mutations, marking Ptch1 as the 
most commonly disrupted gene underlying BCC tumorigenesis40,4142. Ptch1 in BCC 
patients also contain a high level of UV-signature mutations, suggesting chronic exposure 
to environmental UV as the primary risk factor in sporadic BCC43. Mutations in other genes 
of the pathway can also lead to BCC pathogenesis and additional neoplasms. For instance, 
ligand-independent activating mutations in Smo have been found in 6-21% of sporadic 
BCCs 29,42, while Gli2 overexpression induces BCC tumorigenesis in UVB-exposed 
murine models44.  
In addition, sonic hedgehog signaling is reported to regulate stem cell lineage maintenance 
and cancer stem cell renewal in vivo 45,46. Overexpression of SHH in post-natal mice 
resulted in increased stem cells and atypical proliferation, whereas blockage abolished this 
effect46,47. Clinical and molecular evidence suggest BCC carcinogenesis is preceded by 
inappropriate hyperactivation of the hedgehog pathway, which normally regulates stem 
cell renewal, proliferation, and appropriate hair follicle cycling in post-natal 
epidermis33,46,48. Since BCC is a malignancy that originates from epidermal and hair follicle 
stem cells, investigating sonic hedgehog signaling in the epidermal stem cell niche is 
pivotal to understanding BCC pathogenesis.  
1.2 Pathophysiology of BCC 
1.2.1 Anatomy of skin 
In human, the skin is divided into three layers: the epidermis, dermis, and hypodermis. The 
epidermis is further separated into distinct layers based on keratinocyte differentiation. The 
basal layer (stratum basale) contains progenitor cells that rapidly proliferate, giving rise to 
differentiated keratinocytes in the suprabasal layers (stratum corneum, stratum lucidum, 
stratum granulosom, and stratum spinolosum)33. New daughter keratinocytes continuously 
migrate upward, which is terminated at the stratum corneum where matured keratinocytes 
keratinize and undergo apoptosis (Figure 2).  
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Similar to the human integument system, murine epidermis and related appendages are 
renewed independently from distinct niches of adult stem cells49,50. Rapid turnover of the 
interfollicular epidermis (IFE) is maintained by epidermal stem cells in stratum basale 
through mitotic division. In contrast, multipotent cytokeratin-15-expressing (K15)  adult 
stem cells residing in the bulge region and outer root sheath (ORS) of hair follicles are 
responsible for the renewal of the follicles and associated glands51,52. These bulge stem 
cells (BuSCs) are slow-cycling and are quiescent until activated by sonic hedgehog 
signaling29,34,53,54. Daughter cells from BuSC give rise to transiently-amplifying progenitor 
cells, which then rapidly divide symmetrically to renew multiple compartments of the hair 
follicle, such as the inner root sheath (IRS) and hair shaft (Figure 2). Transiently-
amplifying cells in the hair matrix are defined by their more limited plasticity and 
proliferative properties than BuSCs 48. Deprivation of sonic hedgehog signaling results in 
BuSC quiescence and interferes with appropriate progression through hair cycle, since 
BuSCs proliferation is essential for anagen 55,56.  As observed after administration of 
hedgehog inhibitors such as vismodegib and sonidegib, loss of sonic hedgehog signals 
prevents BuSC proliferation and telogen-to-anagen transition, resulting in alopecia of 
human patients57. Interestingly, neural-derived sonic hedgehog signal also triggers 
transient participation of BuSCs in wound healing by stimulating their migration upward 
into the epidermis, where they differentiate into multipotent progenitor cells to renew the 
IFE 49,54.  
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Figure 2: Anatomy of the human skin.  A. Hair follicle structure in human. Multipotent 
adult stem cells reside within the bulge (green), which is a specialized portion of the outer 
root sheath (light orange). Upon stimulation by sonic hedgehog signaling, adult stem cells 
proliferate and daughter cells constitute the outer root sheath, eventually differentiating 
into transiently-amplifying cells residing within the hair matrix (light green), which flanks 
the dermal papillae (yellow). These multipotent progenitors then give rise to the hair shaft 
(grey) and the inner root sheath (blue). B. Layers of the epidermis. Interfollicular epidermis 
renewal depends on the mitotic division of progenitor cells in stratum basale, with newly 
differentiated keratinocytes in the suprabasal layers (stratum spinosum, granulosum, 
lucidum, and corneum).  The figure is adapted from Blue Histology, University of Western 
Australia (http://www.lab.anhb.uwa.edu.au/mb140/).   
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1.2.2 Cancer-initiating cells in BCC 
Previous in vivo studies report BCC commonly arise from SCs residing within the hair 
follicles and the IFE. Aberrant activation of sonic hedgehog signaling causes SCs to enter 
a hyperproliferative state and result in neoplastic outgrowths58–61, whereas its inhibition 
reduces tumor growth in susceptible mouse models and humans. However, the plasticity 
of epithelial SCs adds an additional layer of complexity to the cell origin and epidermal 
compartment of BCC initiation. For example, constitutive sonic hedgehog activation 
driven by Ptch1 loss produces micronodular BCCs arising from the bulge and ORS regions 
in hair follicles. Cell fate tracking of IR-induced BCCs in Ptch+/- mice demonstrate these 
keratinocyte tumors originate exclusively from the K15+ BuSCs 58,60,62, or from their 
progeny in follicles44. In contrast, hedgehog dysregulation resulting from overexpression 
of downstream components, such as mutant SMO (SmoM2) and GLI2 (GLI2△N), result 
in BCC tumors arising from the IFE 59,61. The multipotent K14-expressing adult stem cells 
in stratum basale give rise to BCCs associated with the epidermis. The consensus in the 
field for this discrepancy is that the loss of tumor-inhibitor PTCH1 and the overexpression 
of mutant SMO may produce different biological effects 58,59. The surprising resistance 
against SMO/GLI2-driven tumorigenesis in follicles also suggests the stem cell niche may 
act as a key regulator of the tumorigenic potential of BuSCs in BCC initiation 58,59.  
Clinical and genetic studies conclude Ptch1 inactivation is the most prominent oncogenic 
driver mutation in nodular and micronodular BCC, which are the most prevalent and high-
risk histopathological subtype in sporadic BCC patients respectively63,64. These tumors are 
characterized by cell nests encircled by scant stroma that is prominently separated from the 
surrounding tissue 63–65, consistent with tumors arising from the hair follicles due to Ptch1 
loss. In contrast, superficial BCC originates from the IFE in human patients64, consistent 
with tumors driven by mutant SMO and GLI2 overexpression in murine models59,61. Since 
over 90% of sporadic BCC patients contain Ptch1 inactivating mutation40,43,66, focus has 
been placed on the role of PTCH1 inactivation and downstream consequences in the 
context of BCC initiation.  
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1.2.3  UV radiation and DNA damage  
Neoplastic formation induced by chronic UV exposure is widely accepted as the 
predominant paradigm in skin carcinogenesis 67–71. A strong causal link exists between 
prolonged UV radiation and BCC, as epidemiological and molecular studies report 
approximately 90% of non-melanoma skin cancer are associated with UV exposure 8,43, 72. 
UV radiation can introduce inactivating mutations in tumor-suppressors and 
inappropriately activate oncogenes, resulting in aberrant proliferation and evasion of 
apoptosis in keratinocytes sustaining these mutations. UVB (290 - 320nm) is the most 
carcinogenic UV radiation67,69. Prolonged UVB exposure results in direct DNA damages 
in the form of cyclobutane pyrimidine dimers (CPD), and is associated with the 
accumulation of double-stranded breaks (DSBs) in keratinocytes due to the collapse of 
replication forks67,69. The bulky photodimers interfere with the spatial structure of DNA 
and proper replication, whereas DSBs possess greater risks of losing of genetic materials 
if not repaired effectively. Moreover, evidence suggests chronic UVB exposure augments 
skin carcinogenesis through altering immune cell function in the tumor microenvironment, 
thus promoting sustained inflammatory response and evasion of immune surveillance69,73–
75. Constant production of reactive oxygen species (ROS) by recruited immune cells further 
contributes to neoplastic initiation in a re-modeled microenvironment76. Since the 
epidermis is constantly exposed to environmental UVB, adult stem cells in the stratum 
basale and hair follicles pose as vulnerable targets to damage and carcinogenesis. 
Next-generation deep sequencing (NGS) demonstrates that BCC contains a high 
mutational load compared to metastatic cancer types, such as breast, lung, and ovarian 
cancers77–79. Interestingly, this high mutational load does not always affect keratinocyte 
tumor initiation, which is defined as the irreversible process of a normal cell in acquiring 
the capacity for tumor formation, commonly through oncogenic pathway activation and 
subsequent clonal expansion. NGS analyses detected expanded clonal patches of 
keratinocytes carrying driver mutations in photo-aged skin without histologically-
detectable tumors79–83. These driver mutations, such as mutational inactivation of TP53, in 
UVB-exposed skin occur at a high frequency that is similar to many malignant cancers and 
appear to be under strong positive selection, yet the skin remains physiologically normal. 
Moreover, in vivo studies of human keratinocytes suggest TP53 mutations conferring to 
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increased proliferative capacity are not sufficient to initiate keratinocyte tumors, as they 
were unable to escape the stem cell compartment within the hair follicles to initiate clonal 
expansion84. The central role of DNA damage and related repair mechanisms in skin 
carcinogenesis is undisputed. However, this combination of experimental and genetic 
evidence suggests the existence of an internal barrier, such as tissue architecture or 
microenvironmental signal85–87, that serves as an additional barrier in preventing skin 
tumorigenesis originating from the follicles.  
Currently, there are no effective prophylactics for UVB-induced BCC. Physicians have 
long recommended sun-blocks as the primary preventative method against non-melanoma 
cancer. However, meta-analyses and longitudinal studies report only a slight reduction in 
SCC occurrence, with no significant BCC reduction in compliant patients88-90. Therefore, 
development of preventative measures specific for BCC is imperative. 
1.3 Naked mole-rats in cancer research 
Recent research of cancer-resistant long-lived species yielded potential clues to 
preventative medicine against skin carcinogenesis. Naked mole-rats (Heterocephalus 
glaber) are long-lived rodents (> 30 years in captivity) that display extraordinary longevity 
comparing to mammalian species with similar body mass (i.e: house mouse, 4 years in 
captivity). Aside from their exceptional longevity, naked mole-rats also display surprising 
resistance against carcinogen-induced tumorigenesis91. Only four cases of cancer have 
been reported in these long-lived rodents since captivity, with no reported tumors arising 
from keratinocytes92. Seluanov et al. (2009) have attributed this cancer resistance to the 
hypersensitivity towards contact inhibition (early contact inhibition, ECI). Naked mole-rat 
fibroblasts do not form a confluent monolayer in culture, instead ceasing their proliferative 
activities upon few cell-cell contacts. ECI contributes to cancer resistance by promoting 
cell cycle arrest through inducing p16INK4A expression93.  
The accumulation of epidermal high molecular-weight HA (HMW-HA) has been 
established as the extracellular signal that triggers ECI94. HMW-HA accumulation is 
attributed to two mechanisms in naked mole-rats: enhanced synthesis (enhanced HAS2 
levels) and reduced degradation (low hyaluronidase expression). Importantly, mutant 
fibroblast cell lines lacking the ECI phenotype (p16INK4A-/-) still exhibited continuous 
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production of HMW-HA while wild-type fibroblasts treated with hyaluronidase displayed 
no ECI, therefore placing HA production and signaling upstream of p16INK4A-induced cell 
cycle arrest. Moreover, the ECI response mediated by HMW-HA is transmitted through 
CD44 binding. Upon blocking CD44 with an antibody, naked mole-rat fibroblasts lost ECI 
and reached a higher density in culture. Transformation resistance observed in wild-type 
naked mole-rat fibroblasts was lost upon hyaluronidase and anti-CD44 treatments, 
producing anchorage-independent growth in culture. Decreased expression of p16INK4A is 
also observed in hyaluronidase-treated fibroblasts, implicating that the ECI phenotype is 
modulated by HA/CD44 signaling.  
Recently, HMW-HA accumulation has been reported to induce apoptosis in breast cancer 
cells in 2D culture95. Overexpression of naked mole-rat HAS2 and exogenous HMW-HA 
treatment elevated cytoplasmic cytochrome C expression, caspase activity, ROS 
generation and apoptosis in breast cancer cells. This promotion of apoptosis is associated 
with inhibition of spheroid growth and tumor formation in vivo, along with downregulated 
gene expression involved in proliferation. CD44 expression was significantly upregulated 
in 2D, 3D and in vivo models with the elevation of HMW-HA. Taken together, this suggests 
the interaction between CD44 and large HA polymers mediates cancer cell apoptosis and 
restricts cell cycle progression as a mechanism of cancer resistance in naked mole-rats93–
95.  
1.4 Hyaluronan  
Although the central role of oncogenic driver mutations in carcinogenesis is indispensable, 
mutations alone appear to be insufficient for tumor initiation. Instead, experimental data 
predict the microenvironment can permit or suppress the tumorigenic potential of 
mutations87,96,97. The glycosaminoglycan, hyaluronan (HA), is an example of a 
microenvironmental agent that regulates tumor initiation and progression 98–100. 
Interestingly, HA of different polymer sizes has distinctive biological functions. High 
molecular-weight HA (>500 kDa), such as those observed in naked mole-rats, suppress 
proliferation, migration, and other functions that support tumor growth101,102,. In contrast, 
low molecular-weight HA (<200 kDa; LMW-HA) promote cell proliferation and invasion, 
thus potentiating tumor progression103. HMW-HA also predominates during tissue 
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homeostasis, while LMW-HA accumulates during wound repair and tissue remodeling 
processes100,103,104. Thus, the bio-information of HA is encoded within its polymer size, 
instead of its chemical structure105.  
HA is an anionic, linear, non-sulphated glycosaminoglycan (GAGs) composed of repeating 
disaccharide units of glucuronic acid and N-acetylglucosamine. It facilitates tissue 
hydration via retaining large volumes of water molecules, and participates in regulation of 
tissue homeostasis and biomechanical integrity106,107. HA is ubiquitously present but 
especially abundant in skin, accounting for approximately 50% of the total body HA108. It 
is also present in vitreous of the eye and articular cartilage, where it provides viscoelasticity 
and lubrication106,107. As a crucial component in the microenvironment, HA forms a 
pericellular matrix that is essential for proper ECM assembly and tissue architecture by 
acting as a platform for protein-protein interaction and cell migration106. 
Unlike other GAGs, unmodified HA is synthesized on the interior of the plasma membrane. 
Membrane-associated hyaluronan synthase (HAS) alternatively add UDP-GluUA and 
UDP-GlcNAc substrates to the elongating HA molecule on the inner leaflet of the plasma 
membrane. Elongating HA molecule protrudes through the cell membrane and remain 
attached via a UDP-anchor, forming a peri-cellular coat following post-translational 
modifications. Mammals express three predominate HAS isoforms (HAS1, 2, and 3), 
which are encoded on different chromosomes and exhibit distinct enzymatic properties109–
111. Both HAS1 and HAS2 synthesize large HA polymers (1x106-1x107 Da), while HAS3 
preferentially produce smaller sized HA (1x105 Da).  
HA facilitates complex physiochemical functions despite its simple chemical structure. 
The high molecular-weight native HA polymers (>500 kDa) preferentially produced by 
HAS2 contributes to architectural maintenance and hydration of homeostatic adult 
tissues101,102,111. However, it can be depolymerized enzymatically by hyaluronidases 
(HYAL1-3) into low molecular-weight polymers (<200 kDa) that promote proliferation, 
migration, and inflammation 103. Amongst all hyaluronidases, HYAL2 is often 
overexpressed in the peri-tumor stroma, during damage responses and tissue-remodeling 
processes104. HYAL2 is an extracellular GPI-anchored protein that targets native HA for 
degradation, producing HA fragments of an intermediate size (~20kDa)112,113. The 
resulting HA fragments are then endocytosed and delivered to the lysosome, where 
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HYAL1,3 further process HA into smaller oligomers (<10kDa, hexasaccharides and 
tetrasaccharides). HYAL1, 3 can also be present in the stroma, and are active in a low-pH 
microenvironment to facilitate extracellular HYAL-mediated HA degradation103.  
Under homeostatic conditions, native HA has a rapid turnover rate of under 24 hours in 
skin108. This rapid turnover rate may be required due to the protective functions of HA, as 
it acts as a free radical scavenger under inflammatory conditions114–116. Native HA can also 
be depolymerized by free radicals, such as ROS produced during inflammation and 
exposure to environmental carcinogens (i.e: UV radiation) 117. Excessive degradation by 
ROS and decrease in total skin HA may weaken the protective function of HA, such as 
observed after UVB radiation and in BCC118–120. A homeostatic environment is only 
maintained when the rate of synthesis keeps pace with degradation. When degradation 
exceeds the rate of synthesis, HA fragments accumulate to a significant level, resulting in 
altered microenvironmental signaling121–123. LMW-HA polymers interfere with protein-
protein interactions in the pericellular microenvironment, thus jeopardizing the biomatrix 
integrity124,125. LMW-HA can also outcompete HMW-HA binding with surface receptors 
to alter membrane receptor clustering and downstream intracellular signaling126,127. The 
fragments resulting from native HA degradation are a signal for cellular stress and tissue 
damage. Their presence has been proposed to initiate responses designed to repair tissue 
damage by promoting inflammation and repair. However, cancer cells often upregulate the 
production of LMW-HA in an autocrine/paracrine process that promotes stromal 
remodeling and tumor progression123,128–130.  
1.4.1 HA receptors and signaling  
Native HA and LMW-HA bind to various cell surface receptors, including CD44, Receptor 
for HA-Mediated Motility (RHAMM), Toll-Like Receptors (TLR), and Human 
Hyaluronan Receptor for Endocytosis (HARE)100,131. In keratinocytes, CD44 and 
RHAMM are the two major receptors for surface HA126. CD44 is an integral membrane 
protein that is involved in cell-matrix adhesion, cell-cell adhesion and migration. It 
contains an HA-binding region in the extracellular domain, while its cytoplasmic tail 
regulates intracellular protein signaling126. The common standard form of CD44 contains 
no extra exons, however the insertion of 10 variable exons (exon 6-15) by alternative 
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splicing can generate different isoforms (CD44v1-10) with different physiological 
signaling effects and cellular consequences132. CD44v3-10 predominate in keratinocytes, 
with CD44v3 as the characteristic isoform in homeostatic skin133–135. HA fragments display 
distinct signaling properties comparing to native HA due to their selectivity in receptor-
binding 136,137. Studies report LMW-HA/CD44 binding induces ERK1/2 phosphorylation 
and triggers pro-inflammatory signaling138,139. In contrast, HMW-HA promotes CD44 
clustering at the cell membrane127 but does not trigger ERK1/2 activation136–138. Instead, 
HMW-HA facilitates anti-proliferative and anti-inflammatory responses140, such as 
competitively inhibiting the NFκB signaling induced by LMW-HA/TLR interaction139,141–
144.  
In contrast to CD44, RHAMM is a multi-functional HA receptor that is not highly 
expressed in epidermis under homeostatic conditions. Its expression is typically restricted 
to stratum basale, where the proliferative adult stem cells reside, and sparsely scattered 
throughout the adjacent layer of stratum spinosum in homeostatic epidermis 145. Instead, 
RHAMM overexpression is associated with tumorigenesis and malignant behaviors 146–150, 
specifically in human BCC151. Similar to CD44, RHAMM is capable of interacting with 
both HMW- and LMW-HA, but its protein structure dictates HA fragments with very low 
molecular-weights as its preferred binding partner 126,146. RHAMM often co-complexes 
with other HA-receptors on the plasma membrane, such as CD44 and TLR, to facilitate 
cell migration126.  However, the cellular consequences of RHAMM/HA signaling are 
highly cell-specific and context-dependent. The subcellular compartmentalization of 
RHAMM expression pattern also adds an additional layer of complexity when dissecting 
RHAMM-mediated signaling 126,152. Current literature suggests LMW-HA/RHAMM 
interactions have an instructive role in breast cancer initiation and metastasis148,150,153–155, 
while RHAMM overexpression is found in nodular BCC of patients151. However, the 
precise molecular effects of HA/RHAMM interaction in BCC remains elusive.  
1.4.2 The hyaluronome in carcinogenesis 
HA synthases, hyaluronidases, and HA receptors on the plasma membrane such as CD44 
and RHAMM constitute a complex “hyaluronome”, which regulates HA functions and 
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metabolism. Sustained HA fragmentation is an endogenous danger signal that participates 
in various tissue remodeling processes such as embryogenesis, wound repair, and 
tumorigenesis116,131,156. Specifically, LMW-HA accumulation potentiates the invasive 
tumor phenotype121,156,157 by upregulating hyaluronidase expression and activities. HYAL1 
overexpression correlates with bladder and prostate cancer progression158–161,162, while 
HYAL2 upregulation is associated with malignant cutaneous melanoma and mammary 
gland tumor behavior 163,164. Tumor cells remodel the microenvironment via upregulating 
HAS2, HYAL1 or HYAL2, thus promoting excessive HA synthesis and sustained 
degradation to potentiate invasion and metastasis 165–167. Clinical and experimental studies 
also report elevated LMW-HA polymers promote lymph node metastasis of breast and 
melanoma cells 124,156, while correlating with poor patient prognosis156. Moreover, LMW-
HA is a potent promoter of inflammation, which is a key aspect of the remodeled tumor 
microenvironment. Fragmented HA facilitates macrophage recruitment and differentiation 
into the tumorigenic M2 phenotype via regulating Th1/Th2 cytokine balance, thus 
enhancing local ROS production and further contribute to LMW-HA production168. 
Fragmented HA also induces the phosphorylation and activation of the pro-inflammatory 
NFκB126,142, which is critical in establishing a tumor-permissive microenvironment for skin 
carcinogenesis75.  
In contrast to LMW-HA, native HA restricts cell cycle progression98,127. HAS2 
overexpression and hyaluronidase knockdown reduce tumor growth rate in murine 
astrocytoma cell lines169. Similarly, administration of HMW-HA post-chemotherapy 
significantly inhibits tumor regrowth in colon carcinoma xenograft mice170. Native HA has 
also been reported to reduce the migratory capacity of aggressive cancer cell lines via 
strengthening the cell-cell junctions, thus decreasing the ECM permeability and preventing 
cancerous outgrowths 125. Moreover, native HA is a well-established microenvironmental 
anti-oxidant and ROS scavenger114–116. Recent findings report reduced γ-H2AX foci 
formation, a biomarker for DSB sites, corresponding to HMW-HA 
accumulation114,171,172,173, thus suggesting HA-mediated genoprotection as a possible 
cancer-prevention mechanism. HMW-HA/CD44 interaction is also a well-established 
inhibitor of inflammation through its regulation of the canonical NFκB signaling121,140. 
Mediated by p65/p50 heterodimers, NFκB is a pro-inflammatory pathway that promotes 
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the expression of SHH174,175, the activating ligand in sonic hedgehog signaling, which 
drives BCC initiation.  
Taken together, the current literature suggests that the continuous depolymerization of HA 
enhances the oncogenic potential of the microenvironment. In contrast, HMW-HA 
accumulation limits tumorigenicity by restricting proliferation, invasion, and provides 
genoprotection. However, further conceptual advancement is required to understand the 
distinct size-dependent biological effects of HA in the context of tumorigenesis, and to 
fully harvest the therapeutic potential of HA as a microenvironmental regulator.  
1.4.3 Phosphatidylethanolamine-linked high 
molecular-weight hyaluronan 
Although the accumulation of native HA is associated with offering protection against 
oncogenic assaults and tumorigenesis in mice157,176, human140,171, and naked mole-rats93,95, 
the role of HMW-HA has not yet been described in keratinocyte tumors. Conceptual 
advancements in the past decade have identified the primarily oncogenic driver and the 
cancer-initiating cells in the epidermal microenvironment, and established well-
characterized mouse models to study BCC. Thus, this keratinocyte cancer is an ideal 
disease model to interrogate the effects of microenvironmental agents on regulating the 
tumorigenic potential of cancer-initiating cells. Exogenous applications of HMW-HA have 
been reported to reduce inflammation in vitro 177 and restore skin homeostasis in aged mice 
by promoting epidermal barrier function178, all are critical to suppressing tumorigenesis. 
Although promising, current delivery methods failed to reliably and efficiently distribute 
and retain HA with molecular weights greater than 50kDa in the epidermis and dermis179–
181. This failure is likely due to the large molecular weight and high hydrophilicity of native 
HA, resulting in poor absorption across the hydrophobic stratum corneum182. Rapid 
degradation of exogenous HA formulation by cells and the dependency of receptor 
expression for pericellular coat formation further contribute to the failure of sustained 
HMW-HA delivery into the epidermis182.  
To address these issues, native hyaluronan polymers were linked to 
phosphatidylethanolamine (HA-PE) and incorporated into a topical formulation (patent 
number: US20130059769A1; E. Turley, WorlDiscoveries) 183.  To further investigate the 
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role of HA in offering BCC protection, HA-PE was applied onto the dorsal skin of UVB-
exposed Ptch+/LacZ/Hr-/- mice, which are susceptible to UVB-induced keratinocyte 
tumors184,185. HA-PE allowed the formation of sustained HA-coats on epidermal 
keratinocytes and dermal fibroblasts upon topical application 183. Previously, we 
demonstrated that the formation of HA-coat was independent of major HA receptors on the 
plasma membrane, CD44, but instead was augmented by its linkage with 
phosphatidylethanolamine183. The HA-coat sustained on cell membrane 72 hours post-
administration, which exceeds the normal native hyaluronan half-life in the epidermis183. 
This accumulation of epidermal HA was associated with no histologically-detectable 
keratinocyte tumor formation in BCC-susceptible mice, while control groups 
spontaneously developed keratinocyte tumors after UVB treatment.  
1.5 Animal models in BCC research 
An appropriate animal model should permit the analysis of the molecular pathogenesis 
underlying tumor initiation and allow for the assessment of preventative therapies. Key 
players in the sonic hedgehog pathway are ideal to study BCC in murine models since it is 
the primary oncogenic driver pathway in skin carcinogenesis. Mouse models carrying a 
heterozygous Ptch1 knockout, overexpression of SHH, mutant active SMO, and GLI2 have 
been well-characterized as appropriate models to study sporadic development of BCC58–62. 
Since inactivating mutations of PTCH1 is the most common genetic alteration in human 
BCCs and homozygous loss of Ptch1 is embryonically lethal, Ptch+/- mutants are the most 
appropriate model to study human BCC. A common Ptch+/- model is established by the 
replacing exon 1 and 2 of the Ptch1 allele with a LacZ gene, thus introducing an 
inactivating mutation 186. The Ptch1+/LacZ genotype increases susceptibility of sporadic 
BCC development upon chronic UV exposure (up to 32 weeks) in mice, and allows the 
protein product, β-galactosidase (β-gal), to be used as a reporter for Ptch1 expression 186.  
Mice carrying homozygous mutational inactivation of Hairless (Hr-/-), a transcriptional co-
repressor essential for hair cycling and growth187–189, is another model commonly used in 
dermatologic research concerning keratinocyte tumorigenesis186,190. More commonly used 
to study SCC initiation and progression, Hr-/- mice exhibits disrupted hair follicles and the 
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hairless phenotype (alopecia) after one round of normal hair cycling in newborn 
litters189,191. Biallelic Hr loss accelerates the keratinocyte tumor initiation process 
comparing to haired littermates, without altering the expression of sonic hedgehog and 
BCC-related oncogenic driver pathway components in mice186. Although the morphology 
of hair follicles is disrupted, the cell compositions and functions in the hair follicles are not 
altered191. Hairless phenotype also allowed us to directly apply topical HA-PE cream to 
directly assess the protective effects of HMW-HA. At the molecular and histological levels, 
UV-induced skin neoplasms in Hr-/- models closely resemble tumors in human 
patients186,190, therefore representing an appropriate model to examine keratinocyte tumors 
in mice.  
1.6 Hypothesis and objectives   
Since both carcinogens and initiating driver pathway mutations of BCC are well-
established in human and mice, we decided to interrogate the cancer resistant ability of 
HMW-HA in the context of BCC initiation. Previously, histopathological analyses reported 
the complete lack of keratinocyte neoplasm occurrence after HA-PE treatment in 
chronically UVB-exposed Ptch+/LacZ/Hr-/- mice. Here, I aim to identify the mechanisms of 
HA-mediated resistance against keratinocyte tumorigenesis. HA-PE treatment is 
hypothesized to offer resistance against BCC initiation through inhibiting the oncogenic 
driver, sonic hedgehog signaling pathway, in the epidermis and hair follicles of susceptible 
mice. Therefore, the following objectives were proposed to test this hypothesis.  
Objective 1: Verify HA-PE mediated inhibition of BCC tumor initiation by assessing 
sonic hedgehog signaling in Ptch+/LacZ/Hr-/- mice.  
We chose to investigate the sonic hedgehog pathway to assess tumor initiation, since its 
aberrant signaling is essential for BCC pathogenesis in human and mouse models29,32. The 
overexpression of PTCH1 and GLI1 are well-established molecular markers for signaling 
activities since they are both target genes and regulator of this oncogenic pathway. 
Moreover, the insertion of a promoterless E. coli LacZ gene into Ptch1 allows the usage of 
bacterial β-gal to measure Ptch1 promoter activity. LacZ insertion also introduces a 
heterozygous loss-of-function mutation in Ptch1, thus mimicking the genotype of sporadic 
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BCC patients40,43,66. Therefore, we used β-gal and GLI1 expression as a measurement of 
sonic hedgehog signaling and BCC initiation in Ptch+/LacZ/Hr-/- mice.  
Objective 2: Determine the cellular consequences of HA-PE application in 
Ptch+/LacZ/Hr-/- mice.  
To investigate the mechanisms that are responsible for the suppressive effects against 
UVB-induced BCC tumorigenesis, the cellular effects of HA-PE application on epidermal 
keratinocytes and hair follicle cells were examined. HMW-HA was reported to act as a 
genoprotective agent by acting as a free-radical scavenger114–116, thus the DNA damage in 
epidermis and hair follicles of UVB-exposed mice was assessed. Target genes of sonic 
hedgehog signaling (cyclin D1, BCL2) and associated cellular consequences (cell cycle 
progression and apoptosis) were also investigated in transgenic mice.  
Aim 1: Assess if HA-PE application protected keratinocytes from UVB- and ROS-induced 
DNA damage.  
Aim 2: Examine the effects of HA-PE on cell cycle progression and apoptosis in the 
epidermis of UVB-exposed mice.  
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Chapter 2  
2 Materials and methods 
2.1 Animal studies  
Experiments were approved by and compliant with the standard operating procedures of 
the Animal Use Subcommittee at the University of Western Ontario (2009-060). All animal 
experiments were conducted by Katelyn Cousteils, with detailed breeding schemas and 
conditions reported previously192. Briefly, female Hr-/-/SKH-1 mice (Strain 477, Charles 
River Laboratories, Wilmington, MA, USA) were crossed with Ptch+/LacZ/C57BL/6 male, 
haired mice (Stock number 003091, Jackson Laboratory, Bar Harbor, ME, USA). F1 litters 
between 14 to 21 days of age were genotyped for Ptch+/- heterozygosity. F1 Ptch+/-/Hr+/- 
male mice were crossed with F1 Ptch+/-/Hr+/- female mice, and F2 Ptch+/-/Hr-/- mice were 
utilized for the study.  
Ptch+/-/Hr-/- mice were separated into four experimental groups: no UVB control (No UVB, 
n= 5), UVB-only control (UVB, n=7), UVB with vehicle cream control (UVB + vehicle, 
n=10), and UVB with HA-PE cream (UVB+HA-PE, n=10). An UV-irradiation unit 
(Daavlin Co., Bryan, OH, USA) equipped with an electronic UV-dosage controller186 was 
used to administer UV radiation. Litters between 6 to 7 weeks of age were selected and 
exposed to UV irradiation, which was composed of UVA of 315-400 nm, accounting for 
20% of total energy; and UVB of 290-315 nm, accounting for 80% of total energy. Subjects 
were irradiated for 4 weeks and 26 weeks to study the acute and chronic effects of HA-PE 
on UVB-induced BCC, respectively. Litters received 180 mJ/cm2 of UVB irradiation twice 
per week (Thursdays and Fridays) for 30 to 45 seconds, while vehicle or HA-PE cream 
was applied prior to UVB-irradiation, once daily for five days each week (Monday to 
Friday).  
Lesions and skin abnormalities were measured using digital calipers (500-170-30, Aurora, 
IL, USA), excised using 8-mm punch biopsy from the dorsal back, and processed to be 
paraffin-embedded for histological analyses. Lesion-adjacent phenotypically-normal skin 
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was also excised using an 8-mm punch biopsy, frozen using 70% ethanol and dry ice and 
stored at -80℃.  
Histopathology analysis of skin abnormalities was conducted at the Centre for 
Phenogenomics (Toronto, ON, CA) using paraffin-embedded slides stained with H&E. 
Neoplasia was identified by histological features characteristic of BCC (large nuclei, scant 
cytoplasm, mitotic features), cell morphology, and clonal expansion.  
2.2 Immunohistochemistry  
Immunohistochemistry of paraffin-embedded tissue was conducted as previously 
described193. Briefly, sections were de-paraffinized through two passages of xylene for 15 
minutes each wash and rehydrated through a descending ethanol series (100%, 95%, 70%) 
for 10 minutes each change. Slides were washed in buffer (Table 1) and one change of 
dH2O for 5 minutes each. Antigen retrieval was performed using 10mM sodium citrate 
buffer (pH 6.0) in a standard microwave. Specimen were washed in the two changes of the 
appropriate buffer for 5 minutes each, and endogenous peroxidase activity was inhibited 
by incubating slides in 3% H2O2 for 20 minutes. Non-specific antibody binding was 
blocked by incubating slides in 3% bovine serum albumin (BSA) at room temperature for 
1 hour. Diluted primary antibody was added to each slide and incubated at 4℃ overnight 
in humidifying chambers, with non-immune anti-mouse immunoglobulin (IgG) incubated 
on the negative control (Table 1). Following two washes in the appropriate buffer solution, 
the slides were incubated with 1:100 biotinylated goat anti-rabbit secondary antibody 
(catalog number: E0432, Agilent Technologies, CA, USA) diluted in phosphate buffer 
saline (PBS: 137 mM NaCl, 12 mM phosphate, 2.7 mM KCl, pH 7.4) or Tris-buffer saline 
(TBS: 50 mM Tris-Cl, pH 7.5, 150 mM NaCl) at room temperature (approximately 25℃) 
for 2 hours in humidifying chambers. Streptavidin-conjugated horseradish-peroxidase 
(catalog number: ab7403, AbCam, MA, USA) was diluted in 1xPBS or TBS to 1:1000-
fold and added onto each slide for 30 minutes at room temperature, followed by incubation 
with diaminobenzidine substrate (DAB, catalog number: K3467, Agilent Technologies, 
CA, USA). Counterstaining was carried out using hematoxylin diluted 1:10-fold in ddH2O 
(10143-606, VWR, PA, USA). Sections were dehydrated by passaging through the ethanol 
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series (70%, 95%, 100%) and two changes of xylene. All slides were mounted using 
Cytoseal-60 (catalog number: 8310-16, ThermoFisher Scientific, MA, USA), and dried at 
room temperature.  
2.2.1 Image analysis  
 All sections were scanned using Aperio ScanScope (Leica Biosystems, Wetzlar, Germany) 
and analyzed using ImageJ or QuPath. All quantifications were conducted on the epidermis 
of animal sections, and keratinocytes within the field of view were quantified according to 
their epidermal compartmentalization (suprabasal layer, stratum basale, and hair follicles). 
For intensity quantification, the DAB channel in each image was separated from the 
hematoxylin channel using the “Colour deconvolution” algorithm, and measured using the 
“Pixel measurement” algorithms in ImageJ. DAB-stained brown pixels in slides from all 
experimental groups were compared to the negative control, which was used as the 
threshold. Semi-automatic positive cell counts of all slides were conducted using the 
“Positive cell detection” algorithm from QuPath (v0.1.9) as previously described194, and 
all algorithm-generated data were verified by manual counting.  
2.2.2 Vertical lineage tracing  
Vertical lineage tracing was conducted on γ-H2AX stained paraffin-embedded tissues. 
Daughter cells proliferating from progenitor cells in the stratum basale layer were 
identified, and the number of γ-H2AX positive daughter cells originating from the same 
progenitor cell was quantified through manual cell counting using ImageJ. All suprabasal 
keratinocytes and basal progenitor cells in images were quantified.  
2.3 Immunofluorescence and image analysis  
Immunofluorescence of paraffin-embedded tissue sections was conducted identically to the 
protocol for immunohistochemistry (section 2.2 and 2.2.1) described above, with the 
quenching of endogenous peroxidase omitted. After secondary antibody incubation using 
either Alexa 488-conjugated mouse anti-rabbit IgG (catalog number: A32731, Invitrogen, 
MA, USA) at 1:200-fold dilution or Alexa 555-conjugated mouse anti-mouse IgG (catalog 
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number: A32727, Invitrogen, MA, USA) at a 1:200-fold dilution, slides were washed in 
the appropriate buffer solution (Table 1). Sections were then mounted using DAPI-
containing ProLong Gold anti-fade mounting reagent (catalog number: P36931, 
ThermoFisher Scientific, MA, USA).  
All tissue sections were imaged using IX81 Olympus confocal microscope equipped with 
FV10-ASW 4.2 software at 20x or 40x magnifications. Images were saved in tiff format 
and quantified using ImageJ or QuPath as described above. Keratinocytes within the field 
of view were quantified according to their epidermal compartmentalization (suprabasal 
layer, stratum basale, and hair follicles). To quantify the intensity of antibody 
immunoreactivity, DAPI, FITC and TexasRed channels were first separated in ImageJ 
using the “Split channel” algorithm, and threshold against the negative control. Epidermal 
compartments in each field of view were selected manually, and the “Pixel measurement” 
algorithm was used to detect intensity. Similarly, individual colour channels were separated 
in QuPath and the “Positive cell detection” algorithm was used to detect keratinocytes 
positive for antibody staining as previously described194, and all algorithm-generated 
counts were verified manually. 
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Table 1: Antibodies and buffers used in immunohistochemistry and 
immunofluorescence of paraffin-embedded tissue sections. 
Primary antibody Catalog number Dilution Wash 
buffer 
Antigen 
retrieval buffer 
β-galactosidase  A11132, Life Technologies 
Corporation, CA, USA 
1:200 1xPBS  
 
 
 
 
 
10 mM Sodium 
citrate, pH 6.0 
GLI1 ab151796, Abcam, MA, USA 1:900 1xTBS 
CD44 553130, BD Biosciences, ON, CA 1:200 1xPBS 
RHAMM ab124729, Abcam, MA, USA 1:50 1xPBS 
Phospho-histone 
H2AX (Ser139) 
9718, Cell Signalling Technology, 
MA, USA 
1:150 1xTBS 
Bcl-2 sc-492, Santa Cruz Biotechnology 1:300 1xPBS 
Cyclin D1 ab16663, Abcam, MA, USA 1:100 1xTBS 
Ki67 ab16667, Abcam, MA, USA 1:100 1xPBS 
NFκB-p50 sc-114, Santa Cruz, Biotechnology 1:100 1xTBS 
NFκB-p65 Sc-8008, Santa Crux Biotechnology 1:100 1xTBS 
SMA ab124964, Abcam, MA, USA 1:100 1xPBS 
Cleaved caspase 3 
(Asp175) 
9664, Cell Signalling Technology, 
MA, USA  
1:50 1xTBS 10 mM Sodium 
citrate, 0.05% 
Tween-20, pH 
6.0 
Cytokeratin-15 ab80522, Abcam, MA, USA 1:100 1xTBS 
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2.4 Detection of HA in tissue sections and analysis 
HA detection in paraffin-embedded tissue sections was conducted similarly to the protocol 
for immunohistochemistry described above, with modifications stated below. Following 
de-paraffinization of slides, the antigen retrieval step was omitted. The primary antibody 
was replaced by an HA-binding biotinylated protein (catalog number: K-1203, Echelon 
Biosciences, UT, USA), and incubated at 37℃ for 1 hour. Negative control was established 
by replacing the HA-binding biotylinated protein with 3% bovine serum albumin diluted 
in PBS. Slides were incubated in 3% H2O2 for 15 minutes at room temperature and 
incubated with HRP/streptavidin diluted to 1:1000-fold in 1xPBS. DAB reagents were 
added onto each slide for 20 minutes at room temperature, and counterstained with Harris’ 
Hematoxylin (catalog number: 10143-606, VWR, PA, USA) at 1:10-fold diluted with 
dH2O. All slides were washed in 1xPBS for 10 minutes between each step. Sections were 
dehydrated by passage through the ethanol series and xylene in reverse, and mounted in 
Cytoseal-60. Quantification of HA staining was carried identically to the protocols for 
immunohistochemistry quantification described above.  
2.5 RT-qPCR  
2.5.1 Total RNA extraction from tissue 
RNA extraction from tissue was performed via standard trizol/chloroform extraction 
protocol. All equipment was cleaned with 70% ethanol and RNase-away solution (catalog 
number: 10328-011, Invitrogen, MA, USA). Briefly, approximately 1 gram of frozen skin 
biopsy and 500 μL of trizol (catalog number: 15596018, Life Technologies Corporation, 
CA, USA) were added into a micro-centrifuge tube, and homogenized using a hand-held 
Dounce homogenizer. Fresh 500uL of trizol were added to samples once they are 
adequately homogenized, followed by mixing by inversion and incubated at -20℃ for 5 
minutes. 200 μL of chloroform (catalog number: 423555000, Acros Organics, NJ, USA) 
was added to samples, vortexed for 10 seconds and incubated at room temperature for 3 
minutes. Samples were centrifuged at 4℃ for 15 minutes at 12,000 rpm, with the top 
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aqueous layer transferred into new tubes. Ice-cold isopropanol (500 μL) was added to 
samples and stored at -20℃ overnight. Samples were centrifuged at 4℃ for 30 minutes at 
12,000 rpm, and supernatants were discarded with the pellets washed in ice-cold 70% 
ethanol. Samples were centrifuged at 4℃ for 10 minutes at 7,500 rpm, and the supernatants 
were aspirated. Pellets were air-dried and resuspended in 20 μL of nuclease-free ddH2O, 
with the RNA concentration measured via NanoDrop One/OneC (ThermoFisher Scientific, 
MA, USA). Samples with an A260/280 > 1.9 and A260/230 > 1.7 were used for further 
experiments, and stored at -80℃ until further assays.  
2.5.2 In vitro reverse transcription  
Complementary DNA (cDNA) was synthesized using SuperScript IV VILO Master Mix 
kit (catalog number: 11756050, Invitrogen, MA, USA). 4 μL of SuperScript IV VILO 
master mix solution was incubated with 1 μg of RNA template and nuclease-free water for 
a final reaction volume of 20 μL. Samples were gently mixed at incubated at 25℃ for 10 
minutes to allow primer annealing, followed by incubation at 50℃ for 1 hour to allow 
elongation. Samples were then heated to 85℃ for 5 minutes to inactivate reverse 
transcriptase, briefly centrifuged and stored at -20℃ until further assays were performed.  
2.5.3 PCR reactions and analysis  
RT-PCR was performed to analyze CD44 expression in transgenic mice. Each PCR 
reaction consisted of 20 ng of cDNA template, 0.5 μL of 10 μM forward and reverse 
primers (Table 2), 0.5 μL of GC enhancer, 10 μL of AmpliTaq 360 master mix, and 
nuclease-free ddH2O to reach a total volume of 25 μL. PCR reactions were carried out at 
95℃ for 10 minutes, 94℃ for 30 seconds, 55℃ for 30 seconds, 72℃ for 30 seconds for 
40 cycles, and a final elongation step at 72℃ for 7 minutes using DNA Engine Tetrad 2 
Thermocycler (Bio Rad, CA, USA). All target gene expression was compared with the 
house control gene GAPDH on a 1% agarose gel containing ethidium bromide, and imaged 
using ChemiDocTM XRS+ System (Bio Rad, CA, USA). 
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2.5.4 Real-time PCR reactions and analysis 
RT-qPCR was performed to analyze the mRNA expression of Hyal2, Hyal3, Hmmr, Shh, 
Cccnb1, Cdk4, and Gapdh in transgenic mice. Each PCR reaction consisted of 20 ng of 
cDNA template, 0.5uL of 10uM forward and reverse primers (Table 2), 10 μL of SYBR 
Green PCR Master Mix (catalog number: 4309155, Thermofisher Scientific, MA, USA), 
and nuclease-free ddH2O to reach a total volume of 20 μL. PCR reactions were carried out 
on a 96-well plate at 95℃ for 3 minutes, 60℃ for 10 seconds, and 72℃ for 30 seconds for 
40 cycles using Stratagene Mx3000P system (Agilent Technologies, Santa Clara, CA). Ct 
values were exported from the thermocycler and analyzed using excel according to the 2-
△CT method.  
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Table 2: Primers used in RT-qPCR and RT-PCR.  
Gene Forward primer Reverse primer 
Hyal2 GCAGGACTAGGTCCCATCATC TTCCATGCTACCACAAAGGGT 
Hyal2 TCTGTGGTATGGAATGTACCCT TGCACACCAAAATGGGCCTTA 
CD44s GCCTACTGGAGATCAGGATG GATCCATGAGTCACAGTGCG 
CD44v3 GCCTACTGGAGATCAGGATG TCATTTTCCTCATTTGGCTCCC 
CD44v4 GCCTACTGGAGATCAGGATG TCTGGGTTTGAATGGTTTGGC 
CD44v8 ACAACCCTTCAGCCTACTGC GATCCATGAGTCACAGTGCG 
CD44 v10 CCCAGTGACCCCTGCTAAAA GATCCATGAGTCACAGTGCG 
Hmmr CCTTGCTTGCTTCGGCTAAAA AGCAAAGCTCAATGCAGCAG 
Shh GGCAGATATGAAGGGAAGAT ACTGCTCGACCCTCATAGTG 
Ccnb1 AGCAAATATGAGGAGATGTACC CGACTTTAGATGCTCTACGGA 
Cdk4 AACTGATCGGGACATCAAGG CAGGCCGCTTAGAAACTGAC 
Gapdh 
TGAGGCCGGTGCT 
GAGTATGTCG 
CCACAGTCTTCTG 
GGTGGCAGTG 
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2.6 Enzyme-linked immunosorbent assays 
2.6.1 DNA extraction from tissue 
Approximately 1 gram of frozen tissue sample was incubated in lysis buffer (1M Tris, 0.5M 
EDTA, 10% SDS, 5M NaCl, pH 8.0) and 20 mg/mL proteinase K (Roche, Mannheim, 
Germany) overnight at 55℃ with constant agitation. Samples were centrifuged at 200xg 
for 10 minutes at room temperature, and the supernatants in each sample were transferred 
into new tubes. 100 μL of Protein precipitation solution (catalog number: A975A, Promega 
Corporation, WI, USA) was added to samples and centrifuged at 14,000xg for 10 minutes. 
Supernatants were briefly chilled on ice followed by centrifugation at 14,000xg for 5 
minutes, with pellets discarded. Immediately after, ice-cold isopropanol (500 μL) was 
added to supernatants, mixed by inversion five times and incubated at -20℃ for 30 minutes. 
All samples were centrifuged at 14,000xg for 15 minutes, and pellets were washed with 
ice-cold 70% ethanol. After, samples were centrifuged at 14,000xg for 10 minutes again 
and washed pellets using ice-cold 70%. Resulting pellets were air-dried at room 
temperature and suspended in 20 μL of ddH2O. Sample concentration were measured using 
NanoDrop One/OneC (ThermoFisher Scientific, MA, USA), and stored in -20℃ until 
further use. Only samples with an A260/280 ratio between 1.8 to 1.9 were used in future 
experiments.  
2.6.2 8-oxo-2’-deoxyguanosine ELISA 
Nuclear ROS-adducts 8-oxo-2’-deoxyguanosine (8-oxo-dG) were detected using a 
commercially available ELISA kit (catalog number: 4380-096-K, Trevigen, MD, USA). 
DNA was extracted from frozen tissue as described in section 2.5.1. Samples were diluted 
in nuclease-free ddH2O to 200 μg/mL, and 100X cations (catalog number: 4380-096-05) 
was added for a final 1X concentration. 0.8 μL of DNase I (catalog number: 4380-096-06, 
5 U/uL) and alkaline phosphatase (catalog number: 4386-096-07) were added to each 
sample and incubated at 37℃ for 1 hour separately. Digested samples were aliquoted and 
stored at -20℃ until assayed. 8-oxo-dG standards (catalog number: 4380-096-01, 20 μM) 
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were serially diluted with assay diluent (catalog number: 4380-096-02) to construct a 
standard curve (200 nM, 100 nM, 50 nM, 25 nM, 12.5 nM, 6.25 nM, and 3.13 nM). 25 μL 
of standards, blank and DNA samples were pipetted in triplicates into a 96-well plate pre-
coated with 8-oxo-dG, with 25 μL of anti-8-OHdG monoclonal antibody (catalog number: 
4380-096-03, diluted 1:250-fold in assay diluent) added to each well. The plate was 
covered with a film sealer and incubated for 1 hour at 25℃. All wells were washed with 4 
changes of 1xPBST (137 mM NaCl, 12 mM phosphate, 2.7 mM KCl, pH 7.4, 0.1% Tween-
20) for 30 seconds, with excess liquid aspirated. Goat-anti-mouse IgG-HRP conjugate 
(catalog number: 4380-096-04, diluted 1:500-fold in assay diluent) was added to all wells, 
and incubated at 25℃ for 1 hour. The plate was then washed with 4 changes of 1xPBST 
with excessive liquid aspirated. 50 μL of room-temperature TACS-Sapphire colorimetric 
substrate (catalog number: 4822-096-08) was added to all wells, and incubated for 15 
minutes at 25℃ in the dark. The reactions were stopped by adding 50 μL of 5% phosphoric 
acid to all wells, and absorbance was read immediately at 450 nm.  
The average absorbance for all standards, samples and blanks were calculated, with the 
blank average subtracted from standard and sample averages to determine relative 
absorbance. The log of 8-oxo-dG standard concentration (ng/mL) was plotted against the 
relative absorbance to derive a standard curve, and 8-oxo-dG concentration in samples was 
calculated and interpolated from the standard curve. 
2.6.3 Cyclobutane pyrimidine dimer ELISA 
Protocol was carried at as described by the manufacturer (catalog number: STA-322, Cell 
Biolabs). Briefly, genomic DNA (gDNA) was extracted from tissue samples as described 
in section 2.7.1, and incubated at 95℃ for 10 minutes to denature double-stranded DNA 
(dsDNA) into single-stranded DNA (ssDNA). Samples were briefly chilled on ice, and 
diluted to 4 μg/mL in ice-cold 1xTE buffer (10 mM Tris, pH 8.0, 1mM EDTA). Similarly, 
CPD-DNA standards and reduced DNA provided in the commercial kit were denatured 
into ssDNA via incubation at 95℃ for 10 minutes. Standards were serially diluted to create 
a standard curve (0, 1.56, 3.13, 6.25, 12.5, 25, 50, 100 ng/mL) in ice-cold TE buffer. 
Samples and CPD-DNA standards were added to a 96-well plate, with an equal volume of 
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DNA binding solution added to each well and mixed thoroughly via pipetting. The plate 
was incubated at room temperature overnight with constant agitation. Solutions were 
aspirated and wells were washed twice with 1xPBS, with excess fluid removed by blotting. 
Assay diluent was added to each well to block non-specific binding at room temperature 
for 1 hour. After assay diluent was removed from well, anti-CPD antibody (catalog number: 
232202, Cell Biolabs) were diluted 1:1000 in 1xTE buffer and added to each well and 
incubated at room temperature for 1 hour with constant agitation. All wells were washed 
five times with wash buffer and blotted to remove excess fluid, followed by incubation 
with secondary antibody-HRP conjugate (diluted 1:1000 in 1xTE buffer, catalog 
number:10902, Cell Biolabs) at room temperature for 1 hour on an orbital shaker. Plate 
was washed five times in wash buffer and excess fluid was removed. Substrate solution 
warmed to room temperature was incubated in each well for 20 minutes, stop solution was 
added to each well to stop the enzyme reaction. Absorbance of all wells was read using a 
microplate reader at 450 nm immediately after stop solution addition. Reduced DNA 
standard was used as an absorbance blank, and all DNA samples were assayed in triplicates.  
The average absorbance for all standards, samples and blanks was calculated, with the 
blank average subtracted from standard and sample averages to determine relative 
absorbance. The CPD-DNA standard concentration (ng/mL) was plotted against the 
relative absorbance at OD450nm to derive a standard curve. The CPD concentration in 
extracted DNA was calculated and interpolated using the standard curve. 
2.7 Terminal deoxynucleotidyl transferase dUTP nick 
end labeling (TUNEL) assay  
Detection of apoptosis was carried out using ApopTag Fluorescein In Situ Apoptosis 
Detection Kit (S7110, EMD Millipore, MA, USA) following the protocol provided by the 
manufacturer. Briefly, slides were deparaffinized by passage through two changes of 
xylene (10 minutes each wash) and a descending series of ethanol (100%, 95%, and 70% 
for 5 minutes each wash), followed by one change of 1xPBS for 5 minutes. Slides were 
incubated in freshly diluted proteinase K (20 μg/mL) for 15 minutes at room temperature, 
and washed in 2 changes of 1xPBS for 2 minutes each wash. Equilibration buffer was 
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added to each specimen and incubated at room temperature for 30 minutes. Immediately 
afterward, 55uL of terminal deoxynucleotidyl transferase (catalog number: 90418, EMD 
Millipore, MA, USA) and reaction buffer (catalog number: 90417, EMD Millipore, MA, 
USA) mixture in 1:3 ratio was added to slides, and stored in humidified chambers at 37℃ 
for 1 hour. Negative and positive controls were established by omitting the reaction buffer 
in the mixture and treatment with DNase I (catalog number: 4380-096-06, 5U/uL, Trevigan, 
MD, USA) at 37℃ for 1 hour, respectively. Reaction was stopped by incubating in Stop 
Buffer (catalog number: 90419, EMD Millipore, MA, USA) at room temperature for 10 
minutes, followed by 3 washes in 1xPBS for 1 minute each wash. Room-temperature 
mixture containing anti-digoxigenin conjugate (catalog number: 90426, EMD Millipore, 
MA, USA) and blocking solution (catalog number: 90425, EMD Millipore, MA, USA) 
was added to each specimen, and incubated at room temperature for 30 minutes in the dark. 
All slides were washed in 4 changes of 1xPBS for 2 minutes each wash, and counterstained 
with DAPI-containing ProLong Gold anti-fade mounting reagent. All specimens were 
stored at -20℃ in the dark.  
Images were captured on IX81 Olympus confocal microscope using the negative control 
as the minimal threshold for laser settings. All images were analyzed using ImageJ to 
manually count TUNEL-positive cells in each image (approximately 1000 cells per field), 
with the interfollicular epidermis and hair follicles quantified separately.  
2.8 Hyaluronidase activity ELISA-like assay  
Detection of hyaluronidase activity in whole skin samples was conducted as described 
previously195,196. Briefly, 3 grams of tissue was suspended in ice-cold homogenization 
buffer (5 mM HEPES, pH 7.2; 1 mM benzamidine-HCl) and homogenized using a Dounce 
homogenizer (Ika Works Inc, Wilmington, NC). Lysate was centrifuged at 10,000xg for 
30 minutes, with total protein concentration measured through BCA assay and compared 
to a BSA standard curve.  
A 96-well plate was coated with high molecular-weight human umbilical hyaluronan (200 
μg/mL, H1876, Sigma-Aldrich, MO, USA) diluted in 0.1M sodium bicarbonate solution 
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(pH 9.2) overnight at 4℃. HA-coated wells were washed three times in 1xPBST. Tissue 
samples were diluted in reaction buffer (0.1 M sodium acetate, 0.15 M NaCl, 0.2 mg/mL 
BSA, pH 5.3) and 10 μg of total protein was loaded in each well. Purified bovine 
hyaluronidase (catalog number: H3506-1G, Sigma-Aldrich, MO, USA) and an HA-coated 
well with only reaction buffer were used as the positive and negative control, respectively. 
The 96-well plate was incubated at 37℃ for 6 hours to allow HA digestion. All wells were 
washed thrice in 1xPBST.  
Using hyaluronan enzyme-linked immunosorbent assay kit (catalog number: K-1200, 
Echelon Biosciences Inc., UT, USA), the remainder of HA in each well detected as a 
measurement of hyaluronidase activity. HA detection was carried out according to the 
protocol provided by the manufacturer with modifications stated as below. 100 μL of 
biotinylated HA-binding protein (catalog number: K-1203, Echelon Biosciences Inc., UT, 
USA) was added to all wells and incubated at 37℃ for 1 hour. Wells were aspirated and 
washed with 1xPBST three times, with excessive fluid blotted. Enzyme (catalog number: 
K-1206, Echelon Biosciences Inc., UT, USA) was diluted by adding 6 mL of diluent 
provided by the kit (catalog number: K-1204, Echelon Biosciences Inc., UT, USA), and 
added to each well and incubated at 37℃ for 30 minutes. Wells were aspirated by blotting. 
Substrate buffer (catalog number: K-1208, Echelon Biosciences Inc., UT, USA) and one 
pellet of the substrate, p-nitrophenyl phosphate tablet, were mixed together and added to 
each sample and incubated at room temperature for 40 minutes in the dark. Plate was 
immediately read using a plate reader (Synergy H4 Hybrid Reader, BioTek, VT, USA) at 
405 nm, with OD405nm inversely proportional to the HA remaining in each well after 
hyaluronidase digestion. 
2.9 HA size determination by agarose gel  
2.9.1 HA isolation from tissue  
HA extraction from tissue was conducted as described previously195,196. Briefly, 3 grams 
of whole skin sample was incubated overnight at 50℃ with constant agitation in digestion 
buffer (10 mM Tris-Cl, 25 mM EDTA, 100 mM NaCl, 0.5% SDS) and 20mg/mL 
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proteinase K. EDTA was chelated by adding 27 mM of MgCl2, and proteinase K was 
inactivated at 95℃ for 10 minutes. Nucleic acids were removed by benzonase nuclease 
(500 U/μL, catalog number: E1014, Sigma-Aldrich, MO, USA) digestion at 37℃ overnight. 
The absence of nucleic acid was confirmed by running samples on 1% agarose gel stained 
with ethidium bromide at 100V for 40 minutes. Samples were purified through standard 
phenol/chloroform protocol followed by ethanol precipitation. Briefly, samples were 
mixed with 1:1 v/v phenol/chloroform, and centrifuged at 8,000xg for 15 minutes. The 
aqueous phase was transferred to a new tube, with an equal volume of chloroform added 
and centrifuged at 10,000xg for 15 minutes. This step was repeated twice, followed by the 
addition of 2.5 volumes of ice-cold 100% ethanol to the aqueous phase. Samples were 
stored at -20℃ overnight to maximize precipitation. All samples were centrifuged for 10 
minutes at 14,000xg and supernatants were discarded. Pellets were washed with 4 volumes 
of ice-cold 70% ethanol, and centrifuged for 10 minutes at 14,000xg. Pellets were air-dried 
at room temperature, and resuspended in 20 μL of 10 mM Tris-Cl (pH 8.5). Samples were 
stored at -20℃ until gel electrophoresis.  
2.9.2 Gel electrophoresis and visualization  
The protocol of determining HA polymer size through gel electrophoresis was adapted 
from previous literature195–197. Briefly, agarose was diluted in 1xTAE buffer (40mM Tris, 
20mM glacial acetate acid, 2mM EDTA, pH 8.5) and dissolved in a microwave, followed 
by incubation at 45℃ for 15 minutes. Electrophoresis chambers were filled with 1xTAE 
and ran at 100V for 20 minutes to clear impurities from the agarose gel. Samples were 
separated into two reactions, with one reaction incubated with purified bovine 
hyaluronidase (catalog number: H2506, Sigma-Aldrich, MO, USA) at 37℃ for 1 hour as 
a negative control. Loading dye (0.02% bromophenol blue, 85% glycerol) was added to 
both reactions. The HA polymer size in reactions was visualized on a 2.5% agarose gel, 
and gel electrophoresis was carried out at 90V for 1 hour, followed by 100V for 2.5 hours. 
Agarose gel was placed in staining solution (0.005% Stains-all, 50% ethanol) in the dark 
overnight at room temperature, then briefly de-stained in dH2O for 20 minutes in the dark 
with constant agitation. Afterward, a freshly-diluted concentrated staining solution (0.01% 
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Stains-all, 50% ethanol) was incubated with the agarose gel for 40 minutes. The final de-
staining step was carried out in dH2O for 2 hours in the dark with constant agitation.  
2.10 Statistical analyses  
Experimental data are presented as mean ± standard error mean (SEM), with significances 
detected at p-value < 0.05. All immunofluorescence and immunohistochemistry 
experiments were performed with a sample size of n=3 animals per treatment group, 5 
replicates per animal. All ELISA and RT-PCR experiments were conducted in triplicates. 
Significances were calculated using two-sample t-test or one-way ANOVA, followed by 
Tukey’s test as post-hoc analyses in GraphPad Prism 7 (GraphPad Software, Ca, USA, 
www.graphpad.com) for quantitative analyses for immunohistochemistry.  
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Chapter 3  
3 Results  
3.1 HA-PE application promotes epidermal HA 
accumulation   
To explore the potential role of HA in preventing skin tumorigenesis, HA-PE was topically 
applied onto the dorsal skin of UVB-exposed Ptch+/Lacz/Hr-/- mice. HA-PE application 
significantly increased total HA in the epidermis, hair follicles and the dermis (Figure 3). 
This accumulation corresponded to significantly reduced hyaluronidase-2 (Hyal2) mRNA 
expression, an isoform that preferentially targets surface high molecular-weight HA for 
degradation. In contrast, the mRNA expression level of hyaluronidase-3 (Hyal3), a 
lysosomal isoform that promotes LMW-HA cleavage into oligosaccharides, remained 
unchanged (Figure 4.A). A significant decrease in total hyaluronidase activity in skin was 
also observed after HA-PE application, corresponding to the increased accumulation of 
epidermal HA (Figure 4.B). Since decreased hyaluronidase activity and enhanced HA 
accumulation are associated with reduced tumorigenicity in murine models157,198, I next 
examined sonic hedgehog signaling, which is the primary oncogenic driver underlying 
BCC, in the interfollicular epidermis and hair follicles of UVB irradiated Ptch+/Lacz/Hr-/- 
mice.   
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Figure 3: Detection of HA content in the interfollicular epidermis and hair follicles of 
Ptch+/LacZ/Hr-/- mice following 26 weeks of UVB exposure. A. HA-PE enhanced HA 
staining intensity in epidermal keratinocytes and hair follicle cells. Insets emphasize HA 
content in the hair follicles, with black arrowheads indicating HA expression on plasma 
membrane. Interfollicular epidermis and associated hair follicles are separated from the 
underlying dermis by the black dash line. HA content is detected using an HA-binding 
biotinylated protein and detected via DAB reagent (brown), followed by counterstaining 
with hematoxylin. B. Quantitative analysis of HA content detection in paraffin-embedded 
tissue sections. Intensity of immunoreactivity was measured using ImageJ and threshold 
against a negative control, established by omitting the HA-binding protein incubation, as a 
baseline. All values represent mean and SEM for a sample size of n=3 animals per group, 
with 5 replicates per animal (two-sample t test, * p<0.05).  
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Figure 4: Effects of topical HA-PE administration on hyaluronidase expression and 
activity. A. HYAL2 and HYAL3 mRNA expression in susceptible mice after 4 weeks of 
UVB irradiation. HA-PE application significantly prevented UVB-induced HYAL2 
expression. No changes in HYAL3 mRNA level were observed (n=3 animals/treatment 
group, 4 replicates; two-sample t-test, * p<0.05); B. Total hyaluronidase activity of murine 
skin biopsy samples after 4 weeks of irradiation, detected via an ELISA-like assay. 
Statistical significance was detected via one-way ANOVA, followed by Tukey’s test (n=3 
animals/treatment group, 3 replicates; ** p<0.01). For A. and B, all values are displayed 
as mean ± SEM of samples.  
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3.2 Suppressive effects of HA-PE on sonic hedgehog 
signaling 
To explore the role of epidermal HA accumulation in preventing keratinocyte tumor 
initiation, activation of the oncogenic driver pathway, sonic hedgehog signaling, was 
investigated in Ptch+/LacZ/Hr-/- mice. The insertion of a promoterless LacZ-neo fusion gene 
replaced part of exon 1 and the entire exon 2 in Ptch1, thus producing a heterozygous loss-
of-function mutation and allowing β-gal to be used as a marker for sonic hedgehog 
signaling, since Ptch1 gene expression is induced by the activation of this pathway186. HA-
PE significantly prevented β-gal overexpression in the interfollicular epidermis (IFE) and 
hair follicles of UVB-exposed mice compared to both UVB- and vehicle-treated controls, 
which exhibit aberrant overexpression of β-gal in IFE, sebaceous gland, the bulge region 
and outer root sheath of hair follicles (Figure 5.A,B). To verify HA-PE mediated shutdown 
of this oncogenic pathway in the epidermis and associated epidermal structures, I next 
examined the expression pattern of GLI1, which is a hedgehog target and transcriptional 
factor that is a well-characterized indicator of sonic hedgehog signaling activation. Strong 
nuclear staining for GLI1 is evident in the epidermis and hair follicles of UVB- and vehicle-
treated controls, indicating increased expression and nuclear translocation of this 
transcription factor. In comparison, HA-PE significantly restricted GLI1 expression and 
nuclear accumulation in the IFE and hair follicles back to non-irradiated control levels 
(Figure 6. A,B). GLI1 is minimally expressed in the ORS by both non-irradiated age-
matched control and HA-PE treatment group, whereas aberrant expression is observed in 
all compartments of the hair follicle by UVB- and vehicle-control groups.  
Given LacZ insertion in susceptible mice does not affect the protein product of the second 
Ptch allele, functional tumor-suppressor at the cell membrane can still inhibit downstream 
sonic hedgehog signaling. Therefore, I investigated the expression of SHH, the ligand that 
binds and triggers PTCH1 endocytosis at the membrane. SHH expression was significantly 
reduced post-HA-PE treatment comparing to UVB-treated, vehicle-treated and non-
irradiated controls (Figure 6. C). Taken together, these findings suggest topical HA-PE 
application substantially decrease inappropriate oncogenic sonic hedgehog signaling in the 
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epidermis of UVB-exposed susceptible mice, possibly through the inhibition of SHH 
expression. Since dysregulated hedgehog signaling often results in hyperproliferation 
29,46,66, I next investigated the proliferative responses of keratinocytes to HA-PE application.  
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Figure 5: Suppressive effect of HA-PE application on UVB-induced BCC initiation 
using E.coli LacZ expression as a marker in susceptible mice. A. Immuno-staining of 
bacterial β-galactosidase (green) in murine skin sections counterstained with DAPI (blue). 
Negative and positive controls are established using a mouse that does not express the 
bacterial transgene and a tumor section from a Ptch+/LacZ:Hr-/- mouse in the vehicle control 
group, respectively. HA-PE significantly prevented inappropriate expression of β-gal in 
the epidermis in susceptible mice subjected to 26 of chronic UVB irradiation; B. 
Quantitative analysis of β-galactosidase immuno-staining. Cells in the interfollicular 
epidermis and hair follicles were quantified based on positive immunoreactivity of 
bacterial β-gal through counting in QuPath. All values are displayed as mean ± SEM of 
samples, and statistical significance was analyzed using two-sample t test (n=3 
animals/treatment group, 5 replicates/animal; * p<0.05, ** p<0.01, *** p<0.001). 
 
 
  
41 
 
 
Figure 6: HA-PE prevents oncogenic sonic hedgehog signaling in UVB-exposed 
murine epidermis. A. Global prevention of inappropriate GLI1 expression and nuclear 
accumulation in susceptible mice receiving 26 weeks of irradiation following HA-PE 
administration. Slides are counterstained with hematoxylin and eosin (blue). Brown 
staining indicates positive GLI1 expression by DAB detection. Hair follicle structure is 
depicted in insets with black arrowheads indicating GLI1+ cells. B. Quantitative analysis 
of GLI1 in the interfollicular epidermis and hair follicles. GLI1 expression in each 
epidermal compartment was quantified by counting cells with positive GLI1 
immunoreactivity in the nucleus using QuPath (n=3 animals/treatment group, 5 
replicates/animals; two-sample t test, * p<0.05); C. SHH mRNA expression assessed 
through RT-qPCR. Epidermal enhancement of modified HMW-HA significantly reduced 
SHH expression in skin samples of susceptible mice exposed to 4 weeks of irradiation (n=3 
animals/treatment group, 4 replicates/animal; two-sample t-test, * p<0.05, **** p<0.0001). 
For B. and C, all values are displayed as mean ± SEM of samples. 
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3.3 HA- PE restricts cell cycle progression in 
susceptible mice  
To elucidate the proliferative response of keratinocytes of UVB-exposed susceptible mice 
to HA-PE administration, I conducted immunohistochemistry of cyclin D1 and Ki67 on 
paraffin-embedded tissue sections (Figure 7, 8). Cyclin D1 is a target gene of sonic 
hedgehog signaling, and is often upregulated in BCC tumors and pre-neoplastic skin lesion 
following UVB irradiation199. Quantification of immunohistochemistry demonstrated a 
significant reduction in cyclin D1 expression in the hair follicles by HA-PE (Figure 7.B) 
compared to UVB and vehicle controls, indicating prevention of UVB-induced 
proliferation. As an additional proliferation marker, Ki67 expression in hair follicles was 
quantified by immunohistochemistry (Figure 8.A). No difference of Ki67 expression was 
observed in the suprabasal and basal layer of the interfollicular epidermis between 
irradiated control, vehicle control and HA-PE treatment192. Instead, Ki67 expression in the 
hair follicle following HA-PE treatment was less than that of the UVB and vehicle controls 
(Figure 8.B), especially in the bulge region, where the cancer-initiating cytokeratin-15 
positive stem cells reside (Supplemental Figure 2).  Further, HA-PE treatment maintained 
the typical skin architecture of a distinctive stratum basale separated from suprabasal layers.  
In contrast, this organized tissue architecture is absent in irradiated controls (Figure 7 A), 
marked by the loss of a distinctive boundary between the stratum basale and suprabasal 
layers. Together, these findings predict HA-PE restricts the oncogenic potential of UVB-
exposed hair follicles by inducing mitotic quiescence, possibly via regulating cyclin D1 
expression to restrict G0/G1 progression. Since HA is an extracellular agent and requires 
receptor binding to induce intracellular signaling, I next examined the major HA receptor 
expression in UVB-exposed mice.  
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Figure 7: HA-PE promotes quiescence in hair follicles. A. Immunohistochemistry of 
Cyclin D1 expression in susceptible mice exposed to 26 weeks of irradiation. Slides were 
counterstained with hematoxylin (blue) with cyclin D1 detected via DAB (brown). HA-PE 
significantly prevented cyclin D1 overexpression in the hair follicles (black arrowheads) 
comparing irradiated controls. The distinct separation between suprabasal layers and 
stratum basale, a characteristic indicative of a homeostatic epidermis, is maintained by HA-
PE (black dashed line separating suprabasal layers and stratum basale), whereas irradiated 
controls do not display clear boundaries between the basal and suprabasal layer. B. 
Quantitative analyses of cyclin D1 staining in hair follicles. Cells in each epidermal 
compartment positive for cyclin D1 expression were counted, and the percentage of cyclin 
D1 positive cells per animal was analyzed via two-sample t test (* p<0.05, n=3 
animals/treatment group, 5 replicates/animal). All values are displayed as mean ± SEM of 
samples. 
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Figure 8: Immunohistochemistry analysis of Ki67 expression in hair follicles of UVB 
irradiated mice after HA-PE application. A. Immunohistochemistry of Ki67 (brown), 
showing decreased expression in the bulge region of hair follicles after HA-PE application 
in susceptible mice following 4 weeks of irradiation. Arrowhead indicates the bulge region 
where adult stem cells reside. B. Quantitative analyses of Ki67 staining in hair follicles. 
Ki67-positive cells in each image were counted in QuPath, and the percentages of Ki67+ 
cells per animal were analyzed via two-sample t test (* p<0.05, *** p<0.001, **** 
p<0.0001; n=6 animals/treatment group, 5 replicates/animal). All values are displayed as 
mean ± SEM of samples. 
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3.4 CD44 and RHAMM expression in HA-PE treated 
skin 
Since HMW-HA mediates downstream signaling through interaction with cell surface 
receptors, the expression of CD44 and RHAMM were examined. Immuno-staining 
demonstrated upregulated expression of pan-CD44 in the epidermis and hair follicles 
(Figure 9.A, B), whereas RHAMM expression was unaltered at both the protein and mRNA 
level (Figure 9.B, 10.B). To determine if specific CD44 isoform expression is altered by 
HA-PE administration, RT-PCR experiments were conducted using primers flanking the 
variable regions to identify alternatively spliced variants of CD44 (Figure 10.A). HA-PE 
administration resulted in upregulated CD44v3 isoform expression, which is characteristic 
of homeostatic keratinocytes (Figure 10.A). In contrast, no differences were observed in 
the CD44 standard form (CD44s, Figure 9.A) or variant isoforms (CD44v4, v8, v10) in 
UVB-exposed vehicle and HA-PE treated skin (Supplemental Figure 1). To investigate the 
connection between CD44, HA and prevention of sonic hedgehog signaling in susceptible 
mice, the signaling pathways modulating SHH expression were examined next.  
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Figure 9: CD44 and RHAMM expression in chronically UVB irradiated epidermis 
following HA-PE application. A. Double immunofluorescent labelling of CD44 (red) and 
RHAMM (green) in epidermis using pan-antibodies. Slides were counterstained with 
DAPI shown in blue. RHAMM-/- mouse skin section stained with both CD44 and RHAMM 
to establish a negative control to confirm antibody specificity. HA-PE application 
enhanced CD44 expression in the epidermis of susceptible mice after 26 weeks of 
irradiation, whereas RHAMM expression remains unaltered. In contrast to CD44, 
RHAMM is primarily expressed in sebaceous glands and the outer root sheath of hair 
follicles. B. Quantitative analysis of CD44 and RHAMM expression levels. Intensity of 
immunoreactivity in the interfollicular epidermis was quantified using ImageJ. All values 
are displayed as mean ± SEM of samples (n=3 animals/treatment group, 5 replicates/animal; 
two-sample t test, * p<0.05).  
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Figure 10: Alterations in HA receptor mRNA expression after HA-PE treatment. A. 
CD44v3 expression is increased by HA-PE in susceptible mice after 4 weeks of UVB 
irradiation. Black arrowheads indicate v3 expression (n=3 animals/treatment group, 3 
replicates/animal. Experiment was repeated 3 times); B. mRNA expression level of 
RHAMM assessed by RT-qPCR. No statistically significant differences were observed 
between HA-PE and control groups (n=3 animals/treatment group, 4 replicates/animal; 
two-sample t test). For A. and B, all values are displayed as mean ± SEM of samples. 
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3.5 Effects of HA-PE on NF-κB signaling  
Although current literature does not provide a direct connection between HMW-HA/CD44 
interaction and sonic hedgehog signaling, HMW-HA/CD44 is a well-established negative 
regulator of canonical NF-κB signaling121,140, which is a pathway that can induce SHH 
expression to activate the oncogenic driver sonic hedgehog signaling174,175. Moreover, 
mutational  inactivation of Hr results in sustained inflammation driven by NF-κB signaling, 
which accelerates BCC tumorigenesis in Ptch+/LacZ/Hr-/- mice186. To explore the role of NF-
κB signaling in relation to HA-mediated inhibition of oncogenic sonic hedgehog signaling, 
nuclear localization of the p50 and p65 subunits were assessed through immunostaining 
analysis of paraffin-embedded tissue sections. HA-PE significantly prevented UVB-
induced nuclear localization of p50 in the interfollicular epidermis and hair follicles of 
UVB-exposed mice (Figure 11). However, no difference in p65 localization was detected 
between vehicle control and HA-PE-treated mice as evident by its nuclear translocation. 
Since only p65 in the p65/p50 heterodimer possesses a trans-activating domain that can 
promote the expression of pro-inflammatory genes200, these results indicate that HA-PE 
does not suppress the canonical NF-κB pathway. Therefore, I next assessed whether HA-
PE suppressed UVB-induced DNA damage as a mechanism of tumor prevention.   
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Figure 11: Nuclear NFκB localization in the epidermis of Ptch+/LacZ/Hr-/- mice after 4 
weeks of UVB irradiation. HA-PE significantly prevented UVB-induced nuclear 
localization of both subunits in the interfollicular epidermis. However, this prevention of 
p65 localization was not unique to HA-PE application since vehicle control demonstrated 
similar suppressive effects. Quantitative analyses of p50 and p65 nuclear localization was 
conducted by counting cells exhibiting positive immunoreactivity in the nucleus. All cells 
in the interfollicular epidermis and hair follicles per image were quantified in QuPath. 
Statistical analysis was conducted using two-sample t test (n=3 animals/treatment group, 5 
replicates/animal; * p<0.05). All values are displayed as mean ± SEM of samples. 
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3.6 Keratinocytes are not protected from DNA damage 
by HA-PE in susceptible mice 
To investigate the potential genoprotective role of HMW-HA114–116,166–168, on keratinocytes 
and adult stem cells in susceptible mice, DSBs and UVB-/ROS-signature mutations were 
quantified by immunohistochemistry and ELISA assays. Interestingly, the suppression of 
BCC initiation is not associated with a detectable reduction in DNA damage (Figure 12, 
13). A significant increase in γ-H2AX foci formation in cells within the interfollicular 
epidermis and hair follicles was associated with UVB treatments, possibly due to the 
collapse of replication forks. However, a similar level of DSBs was observed in both the 
vehicle control and HA-PE-treated mice (Figure 12.A,B). To assess whether differences in 
ROS-induced and direct UVB-induced damage existed between the control and 
experimental groups, ELISA was performed to examine 8-oxo-dG and CPD formations in 
susceptible mice (Figure 13. A, B).  Again, no significant differences in UVB- and ROS-
induced DNA damage were detected between the irradiated vehicle control and HA-PE-
treated group. Vertical lineage tracing of proliferating progenitor cells originating from the 
stratum basale was used as a preliminary method to assess DSB repair activity in the 
epidermis. However, these analyses demonstrated no significant differences between all 
experimental groups (Figure 12. C). predicting similar repair activities between control and 
experimental groups are similar. Collectively, these findings demonstrate that the mice 
receiving HA-PE treatment exhibit a similar DNA damage load in IFE and hair follicles as 
the UVB- and vehicle-treated controls, and that differences in DNA damage, and 
potentially mutational load, do not account for HA-PE suppression of BCC. Since the 
accumulation of DNA damage may overwhelm the repair machinery and trigger 
programmed cell death, I next examined apoptosis as a potential mechanism in the removal 
of these harmful cells. 
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Figure 12: HA-PE does not alter the double-stranded breaks in the epidermis of 
susceptible mice after 4 weeks of UVB irradiation. A. Immunohistochemistry of γ-
H2AX in paraffin-embedded tissue counterstained with hematoxylin (blue). Brown 
staining is indicative of γ-H2AX foci formation. B. Quantitative analysis of γ-H2AX foci, 
a marker for double-stranded DNA breaks, in the epidermis and hair follicles. Cells in the 
interfollicular epidermis with strong  γ-H2AX  immunoreactivity were quantified, and the 
percentage of γ-H2AX positive cells in each epidermal compartments were analyzed for 
statistical significance. However, foci formation is not significantly different between 
control and treatment groups; C. Vertical lineage tracing of damage-sustaining progenitor 
cells and γ-H2AX+ daughter cells in the interfollicular epidermis. The percentage of 
daughter cells positive for γ-H2AX foci within a lineage was quantified thorough QuPath 
by counting. For B, and C, two-sample t test was conducted to assess statistical significance 
(* p<0.05; n=3 animals/treatment group, 5 replicates/animal). All values are displayed as 
mean ± SEM of samples. 
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Figure 13: ROS- and UVB-induced DNA damages are not altered by HA-PE 
application following 4 weeks of irradiation. ROS/UVB-induced DNA damages are 
measured by the ROS-adduct 8-oxo-dG and cyclobutane pyrimidine dimer (CPD) 
formation in extracted DNA, respectively. No statistically significant difference in DNA 
damages are observed between irradiated, vehicle-treated controls, and HA-PE treated 
group. Statistical analysis was conducted by two-sample t test, experiments were repeated 
3 times (* p<0.05, ** p<0.01; n=3 animals/treatment group, 5 replicates/animal). All values 
are displayed as mean ± SEM of samples. 
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3.7 HA-PE application promotes selective apoptosis in 
hair follicles  
BCL2 is a pro-survival protein and a target gene that is upregulated by sonic hedgehog 
signaling in BCC tumorigenesis, and is often over-expressed to facilitate cancer cell 
survival by preventing cytochrome c release from the mitochondria201,202. To elucidate 
whether apoptosis contributes to HMW-HA-mediated resistance against BCC initiation, I 
first quantified BCL2 expression in the epidermis and hair follicles of susceptible mice. 
Expression of epidermal and follicular BCL2 was suppressed following HA-PE application 
in UVB-irradiated mice, whereas UVB- and vehicle-treated controls exhibited an elevation 
of this pro-survival protein in the epidermis and hair follicles (Figure 14).   BCL2 is an 
early participant in the apoptosis cascade202.  To verify these results and to establish 
whether keratinocyte apoptosis is altered by HA-PE, TUNEL assay, which marks late-stage 
apoptosis, was quantified.  Interestingly, HA-PE promotes apoptosis in cell subsets within 
the outer root sheath and bulge of hair follicles, where the K15+ stem cells that are known 
to be cancer-initiating in the Ptch+/LacZ mouse model reside (Supplemental Figure 2)58,60–62. 
Apoptosis in these hair follicle regions was uniquely observed in HA-PE treatment, 
whereas control groups only exhibited apoptosis of suprabasal keratinocytes near the 
stratum corneum that is typical of normal keratinocyte turnover (Figure 15).  
To further identify the nature of these hair follicle stem cells, I double-labeled paraffin-
embedded tissue sections with a marker for BuSCs, K15, together with a marker for 
apoptosis, caspase 3. Immunofluorescent co-localization analyses demonstrated that 40% 
of total K15+ cells in the hair follicles are apoptotic, as indicated by positive caspase 3 
expression at week 26 of irradiation (Figure 16.A,B). Consistent with these data, K15+ cells 
were continuously lost between week 6 and 26 following HA-PE administration, while the 
number of K15+ cells in non-irradiated, UVB-exposed and vehicle controls remained 
constant (Figure 16.C).  Given K15 is a well-established marker of BuSCs 61,203,204 that can 
give rise to BCC58,60,62, these data suggest HA-PE promotes the removal of these K15+ 
stem cell via apoptosis as a mechanism of cancer prevention. To verify K15+ cells are the 
cancer-initiating cells in this model, I next investigated the origin of tumors through 
examining the histopathology of identified BCCs in Ptch+/LacZ/Hr-/- mice.  
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Figure 14: HA-PE reduces pro-survival BCL2 expression in the interfollicular 
epidermis and hair follicles of susceptible mice after 26 weeks of UVB irradiation. A. 
Immunohistochemistry of BCL2 detected via DAB (brown). Black arrowheads indicate 
BCL2+ cells in the bulge of hair follicles; B. Quantitative analyses of BCL2 expression in 
the epidermis and hair follicles. Percentage of cells positive for BCL2 immunoreactivity in 
the interfollicular epidermis and hair follicles was quantified via counting in QuPath. All 
values are displayed as mean ± SEM of samples, and analyzed using two-sampled t test (* 
p<0.05, ** p<0.01; n=3 animals/treatment group, 5 replicates/animal). 
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Figure 15: HA-PE enhances apoptosis in the outer root sheath and bulge region of 
hair follicles of mice following 26 weeks of irradiation. A. TUNEL analysis of paraffin-
embedded tissue. Apoptotic cells are labeled in green and counterstained with DAPI (blue). 
White arrowheads indicate apoptotic cells in hair follicles; B. Quantitative analysis of 
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apoptotic cells in the hair follicle. Five images were taken per sample, and the percentage 
of apoptotic cells in was quantified through counting cells with green fluorescence per 
image. All values are displayed as mean ± SEM of samples. Two-sample t test was 
conducted to assess significance (* p<0.05, n=3 animals/treatment group, 5 
replicates/animal). 
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Figure 16: HA-PE enhances apoptosis in K15+ adult stem cells in hair follicles of UVB-
irradiated susceptible mice. A. Double-labeled immunofluorescent analysis of K15 (red) 
and caspase 3 (green), counterstained with DAPI (blue). White arrowheads indicate co-
localization of K15 and caspase 3 in hair follicles of Ptch+/LacZ/Hr-/- mice after 26 weeks of 
irradiation; B. Quantitative analyses of immunofluorescent staining. All K15 cells positive 
for caspase 3 staining in hair follicles were counted, and analyzed via two-sample t test (* 
p<0.05; n=3 animals/treatment group, 5 replicates/animal); C. Number of K15+ cells in 
hair follicles of susceptible mice after 4 and 26 weeks of irradiation. Cells displaying 
positive immunoreactivity for K15 in each image were counted (approximately 500 cells 
per image) and analyzed via two-sample t test (* p<0.05, *** p<0.001; n=3 
animals/treatment group, 5 replicates/animal). For B. and C, all values are displayed as 
mean ± SEM of samples. 
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3.8 Immunohistochemical analysis of UVB-induced 
BCC tumors in Ptch+/LacZ/Hr-/- mice  
To elucidate the epidermal compartment and verify the cancer-initiating cell of BCC 
tumorigenesis in our mouse model, I examined the histopathology of paraffin-embedded 
macroscopic tumor sections from the two control groups as described previously58,62. BCC 
tumors driven by Ptch1 loss are characterized by a radiating, branching organization 
reminiscent of hair follicle differentiation in this model. These micronodular tumors 
displayed scarce stroma and sparse blood vessels, with cells organized into irregularly 
shaped nests. In certain portions of the tumor, elongated or spindle-like cells with a 
minimal degree of nuclear palisading were observed (Figure 17.A, inset), while a 
prominent cleavage was present between surrounding connective tissue and tumor stroma 
(Figure 17. A). Interestingly, BCCs originating from the follicles often display 
inappropriate myoepithelial differentiation, as seen in sporadic human BCC and 
susceptible mouse models62,205,206. Since smooth muscle actin (SMA) is a well-established 
marker for myoepithelial differentiation, I therefore conducted immunohistochemistry to 
examine SMA expression in macroscopic BCC tumors. Strong intracytoplasmic SMA 
immunoreactivity is detected in BCCs and hair follicles of UVB-exposed tumor-adjacent 
skin, but was absent in the stratum basale and suprabasal layers of Ptch+/LacZ/Hr-/- mice 
(Figure 17.B,C). Interestingly, a direct association between these keratinocyte tumors and 
hair follicles was often observed. Rare initial phases of this keratinocyte tumor originating 
from the bulge region (Figure 17.D) and ORS (Figure 17. D, inset) of hair follicles were 
detected in irradiated Ptch+/LacZ mice, with strong K15 immunoreactivity in peripheral cells. 
Similarly, K15 expression was also detected in the peripheral cells of tumor nests in 
macroscopic BCCs identified as BCC by pathologists (Figure 17.E). Together, these data 
suggest that the UVB-induced BCCs in Ptch+/LacZ/Hr-/- mice are associated with the hair 
follicles, and likely originate from the K15+ adult stem cells that are present in the bulge 
and ORS regions.  
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Figure 17: Immunohistochemistry analyses of UVB-induced BCC tumors. A. UVB-
induced BCCs in Ptch+/LacZ/Hr-/- mice are characterized by irregularly shaped nests 
organized in a radiating pattern, with scarce stroma and blood vessels. Insets and 
arrowheads show elongated cells in small, irregular nests with minimal nuclear palisading. 
B. Expression pattern of smooth muscle actin (SMA) in macroscopic BCC tumors. SMA 
was present in both the tumor stroma and the cytoplasm of tumor cells. C. Strong SMA 
expression detected in the tumor-adjacent hair follicle of UVB-exposed vehicle control. 
No SMA immunoreactivity was observed in stratum basale or suprabasal epidermis. D. 
BCC tumors in Ptch+/LacZ/Hr-/- mice are directly associated with the hair follicles. Rare 
initial stages of BCC exhibit atypical outgrowth arising from the approximate region of the 
bulge (white arrowhead) or outer root layer sheath (inset) that are focally-positive for K15 
expression (red). E. K15 expression (red) in macroscopic BCCs. Similar to K15 expression 
in the atypical outgrowth originating from hair follicles, peripheral cells in macroscopic 
BCC are strongly positive for K15 immunoreactivity.  
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Chapter 4  
4 Discussion  
4.1 HA-PE phenocopies the cancer-resistant naked 
mole-rat to prevent carcinogenesis in susceptible mice 
Once thought to be an inert component of the ECM, HA is now recognized as a dynamic 
molecule that facilitates extracellular protein-protein interaction and intracellular 
signaling106,131,146. The loss of native HA in epidermis is characteristic in aging, 
inflammation, chronic UV exposure, and tumorigenesis106,107,118. Previous studies report 
HMW-HA accumulation elicits suppressive effects on murine astrocytoma and colon 
carcinoma xenograft tumor growth 169,170. Further, HMW-HA arrests breast cancer cell 
growth in vitro and spheroid growth, marked by downregulated cyclin D1 and PCNA 
expression95,176 To our knowledge, this is the first study to examine the effects of epidermal 
HMW-HA enhancement on keratinocyte carcinoma initiation. I demonstrated hyaluronan-
phosphatidylethanolamine polymers (HA-PE) significantly increase large HA polymer 
content in the epidermis (Figure 3). HA-PE application suppresses hyaluronidase activity 
and HYAL2 expression (Figure 4), an extracellular hyaluronidase that degrades native HA, 
predicting the accumulated epidermal HA is the high molecular-weight species. Moreover, 
the topical application of HA-PE prevented UVB-induced histologically-detectable BCC 
tumor initiation as detected by histology and inhibition of and significantly blocked Ptch1 
promoter expression in susceptible mice (Figure 5).  
Previous in vivo and cell studies demonstrate sonic hedgehog hyperactivation drives BCC 
tumorigenesis28,29,33,207, and its inhibition leads to reduced proliferative capacity and tumor 
growth208,209. Specifically, animal studies suggest sonic hedgehog signaling driven by loss-
of-function mutation in Ptch1 directly causes BCC originating from the bulge58,60,62, but an 
IFE with hyperactive sonic hedgehog signaling may also constitutive a permissive 
microenvironment for BCC initiation58,59,61. Moreover, HA is a recognized agent in 
mediating maintenance and support of stem-cell niches, including the bulge within hair 
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follicles210. In association with HA accumulation, we show that β-gal staining measuring 
Ptch1 promoter expression is significantly reduced in the IFE and hair follicles (Figure 5), 
indicating suppression of sonic hedgehog signaling in UVB-exposed Ptch1+/- mice. The 
expression and nuclear translocation of the transcriptional factor GLI1, another well-
established marker for sonic hedgehog activation, is similarly suppressed by HA-PE in IFE 
and follicles (Figure 6.A,B). Decrease in  sonic hedgehog signaling is further verified by 
assessing target gene CNND1 (Figure 7) and BCL2 (Figure 14) expression, which were 
significantly diminished in susceptible mice after HA-PE application. Interestingly, HA-
PE reduced the activating ligand SHH expression (Figure 6.C), suggesting a mechanism of 
suppressing the hedgehog pathway. Taken together, our data predict HA-PE prevents 
UVB-induced BCC by inhibiting aberrant sonic hedgehog signaling in two epidermal 
compartments: the hair follicle bulge, and the IFE. HA-PE targets SCs in the bulge via 
restricting sonic hedgehog signaling to a level similarly observed in non-irradiated controls, 
and limits the tumorigenic potential of stem cells in stratum basale via preventing sonic 
hedgehog signaling in IFE.  
This prevention of tumorigenicity was associated with restricted cyclin D1 and Ki67 
expression in the hair follicles of susceptible mice (Figure 7, 8). CCND1, a target gene of 
sonic hedgehog signaling and mediator of G1-S progression, was significantly restricted 
but not extinguished in the hair follicles (Figure 7), thus further verifying decreased sonic 
hedgehog signaling following HA-PE application. Similarly, Ki67 expression was also 
significantly reduced by HA-PE application in the bulge region of hair follicles, where the 
adult stem cells reside (Figure 8). Together, these data predict HA-PE promotes mitotic 
quiescence in UVB-irradiated hair follicles to limit their oncogenic potential.  
In naked mole-rats, large HA polymers are also protected from degradation by reduced 
extracellular hyaluronidase activities94. HMW-HA accumulation confers cancer resistance 
in this species via promoting contact inhibition hypersensitivity through inducing cyclin-
dependent kinase inhibitor p16INK4A/B expression94, 95, thereby promoting quiescence in 
vitro as reflected by the decreased PCNA expression95. The effects of HA-PE reported here 
therefore phenocopy the properties of HMW-HA in the long-lived rodent naked-mole rat 
by increasing HA polymer accumulation, downregulating hyaluronidase activity, inducing 
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relative mitotic quiescence, and exerting an anti-tumorigenic effect. However, the protein 
isoform (p16INK4A/B) responsible for ECI in naked mole-rats is not expressed in mice93,94. 
Thus, further examinations of mammalian contact inhibition pathways (i,e: Hippo/YAP) 
may shed new lights on the involvement of contact inhibition in the prevention of 
keratinocyte carcinogenesis. Moreover, HA-PE elicited apoptotic responses in the known 
cancer-initiating subpopulation of adult stem cells in this susceptible model, whereas 
HMW-HA produced by H. glaber was reported to induce apoptosis in breast cancer cells 
non-specifically95. To my knowledge, the effects of H. glaber HMW-HA on cancer stem 
cells have not been investigated. Here, the promotion of mitotic quiescence and apoptosis 
appear to be linked to an effect of HA-PE on sonic hedgehog signaling, as cyclin D1 and 
BCL2 are target genes of this oncogenic signaling pathway. 
To begin to identify the mechanisms behind HA-PE block in hedgehog signaling and BCC 
initiation, I examined the expression of the major HA receptors in keratinocyte. CD44 is 
the major keratinocyte HA receptor133,135 and is a promising target in facilitating the tumor 
suppressive effect of HA-PE because CD44 mediates the cancer resistance of HMW-HA 
in naked mole-rats 94,95. Moreover, CD44 is essential for several HMW-HA-mediated 
suppression of proliferation126,138, tumor growth126,169,170, and invasion125,157. Keratinocytes 
in homeostatic epidermis primarily express CD44v3-v10, with v3 being the most 
prominent isoform135. Here, we report that HA-PE increased CD44 protein expression in 
the epidermis and hair follicles (Figure 9) and maintained CD44v3 isoform expression, 
which is characteristic of homeostatic keratinocytes (Figure 10.A) that was lost in UVB 
exposed controls. In addition, immunohistochemistry demonstrated that the interfollicular 
epidermis of HA-PE treated mice retained a distinct stratum basale and organized 
suprabasal layers following UVB exposure. In contrast, this tissue architecture indicative 
of a homeostatic epidermis was lost in irradiated controls, as the stratum basale cannot be 
distinguished from suprabasal layers in the epidermis (Figure 7.A). Taken together, the 
findings here predict epidermal HA maintains homeostasis in the interfollicular epidermis 
via promoting CD44v3 isoform expression and maintaining the appropriate epidermal 
architecture. Since CD44 is the primary receptor that is responsible for the HA-mediated 
cancer resistance in naked mole-rats93,94, it is possible that HA-PE exerts its anti-
tumorigenic effects through interaction with CD44 in the epidermis and hair follicles.  
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4.2 HA-PE mediated suppression is not orchestrated 
through canonical NF-κB signaling  
A direct effect of CD44 on sonic hedgehog pathway activity has not been previously 
reported to my knowledge.  However,  HMW-HA/CD44 signaling is a well-established 
inhibitor of canonical NFκB signaling, a pro-inflammatory pathway that promotes SHH 
expression and activation of sonic hedgehog signaling174,175. Previous studies report 
canonical NFκB signaling, activated by the p65/p50 heterodimer, is essential for skin 
carcinogenesis in mice75,186. For example, the p65 inhibitor SSZ significantly reduces the 
nuclear translocation of canonical NFκB and UVB-induced BCC tumor load in 
Ptch+/LacZ/Hr-/- mice, although SSZ does not completely prevent tumor initiation in these 
susceptible mice186. Unexpectedly, HA-PE did not alter p65 nuclear translocation (Figure 
11), possibly due to altered receptor clustering at the membrane. Since canonical NFκB 
signaling requires the dimerization and translocation of p65/p50 subunits, the lack of 
difference in p65 translocation suggests that canonical NFκB signaling was not 
significantly affected by HA-PE treatment. In contrast, p50 nuclear translocation in 
susceptible mice was significantly prevented by HA-PE application relative to UVB-
exposed vehicle control (Figure 11), predicting suppression of the non-canonical NFκB 
pathway. Nuclear p50 homodimer accumulation and constitutive kappaB-binding 
mediated by non-canonical signaling are characteristic of skin neoplasms in mice 211,212. In 
Ptch+/LacZ/Hr-/- mice, non-canonical NFκB signaling is reported to accelerate tumor growth 
by creating a pro-inflammatory microenvironment, and augment BCC pathogenesis 
through upregulating the activating ligand SHH expression to sustain sonic hedgehog 
signaling  212. It is well-established that the p50 subunit does not contain a trans-activating 
domain. Therefore, an additional trans-activator, such as BCL3, is required to for p50 
homodimer to acquire transcriptional activity212,213. BCL3 overexpression is associated 
with stabilization of the p50 homodimer in squamous cell carcinoma211, and enhanced 
BCL3 activity is associated pathogenesis of various neoplasms214,215. Moreover, BCL3 
knockdown significantly reduces PTCH1, GLI1 and GLI2 expression in murine BCC cells, 
thus predicting crosstalk between the two pathways212. In this context, HA-PE may 
suppress sonic hedgehog signaling by preventing non-canonical NFκB-induced SHH 
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expression212. Future experiments should be conducted to investigate the role of HMW-
HA, CD44 and possibly other HA receptors (i.e: Toll-like receptors) in modulating the 
non-canonical NFκB pathway in the context of BCC tumorigenesis, and further examine 
the relationship between p50 homodimers and sonic hedgehog signaling.  
4.3 HA-PE promotes apoptosis of DNA-damaged 
K15+ cancer-initiating stem cells in hair follicles 
UVB is a well-documented environmental carcinogen that threatens genome integrity via 
directly inflicting structural alterations in DNA, such as promoting dimer formation also 
add ROS damage, which is not a direct effect. Mice and humans employ various strategies 
to ensure genome integrity against UVB insults, such as the production of UV-absorbing 
pigments, expression of anti-oxidants, and repair mechanisms including base and 
nucleotide excision repair 67,68,76. However, these mechanisms do not completely protect 
DNA from UV, and damage accumulation is regarded as the primary skin carcinogen 69,71. 
Previous studies have characterized HMW-HA as a genoprotective agent by its ability to 
scavenge epidermal ROS. For example, HMW-HA reduced γ-H2AX foci formation, 
intracellular ROS levels, and damage-induced apoptosis of human corneal and alveolar 
epithelial cells 114,171,172. It is therefore surprising that HA-PE-mediated suppression of 
BCC is not associated with reduced DNA damage in UVB-exposed mice (Figure 12, 13). 
No significant differences were observed in γ-H2AX foci formation, nuclear DNA-
associated ROS adduct 8-oxo-DG, and UVB-induced CPD in UVB controls and HA-PE 
treated epidermis and hair follicles. As a preliminary assessment of DSB repair in the 
epidermis, I performed a vertical lineage tracing of proliferating γ-H2AX+ progenitor cells 
in the stratum basale and associated γ-H2AX+ daughter cells (Figure 12. C). The number 
of γ-H2AX-positive daughter cells that originated from the same basal stem cell served as 
a reflection of DSB escaping DNA repair in the epidermis. The number of γ-H2AX+ 
progenies in the suprabasal layers was not significantly different between experimental 
groups, suggesting the efficiency of DSB repair was not significantly altered by HA-PE 
application in the epidermis. Although my findings do not support previous reports of the 
genoprotective function of HA, they are consistent with previous studies showing that 
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UVB-exposed eyelid keratinocytes sustain a high level of DNA damage but do not undergo 
neoplastic transformation79–83. Deep next-generation sequencing shows a prevalent and 
high mutational load in oncogenic driver mutations of phenotypically-normal skin without 
detectable tumor development, suggesting that an innate barrier exist that restricts the 
carcinogenic potential of driver mutations79,83,86. 
Although the precise downstream mechanism remains unclear, apoptosis is a well-
established mechanism of preventing carcinogenesis. Apoptosis is triggered when DNA 
damage accumulation overwhelms the repair machinery, or by blocking signaling of 
pathways that normal or tumor cells rely upon for proliferation, survival, and renewal. In 
UVB-exposed Ptch+/LacZ/Hr-/- mice, HA-PE restricts proliferation (as detected by 
decreased Ki67 expression, Figure 8) and promoted apoptosis cell subsets in the ORS and 
bulge of hair follicles, which were uniquely observed in HA-PE treated groups (Figure 15). 
In human and mouse, the ORS and bulge regions contain slow-cycling K15-expressing 
stem cells, which can migrate into the stratum basale to transiently participate in wound 
healing upon stimulated by sonic hedgehog signaling. In Ptch+/- mice, K15+ cells and their 
progenies have the potential to give rise to BCC after chronic UVB exposure. Here, double-
labelling immunofluorescence demonstrated these apoptotic subsets in the hair follicles 
were K15-positive (Figure 16). Intriguingly, apoptotic K15+ cells were not observed in the 
stratum basale following HA-PE treatment (Figure 16. A), possibly due to the lack of 
migration into the interfollicular epidermis (Supplemental Figure 2.B). HA-PE suppression 
of sonic hedgehog signal in the microenvironment may prevent K15+ stem cell migration 
into the IFE, since paracrine sonic hedgehog signal from the dermis and innervated neurons 
are required to initiate this process. Moreover, approximately 40% of total K15+ adult stem 
cells were apoptotic after 26 weeks of irradiation and HA-PE application. Consistent with 
this finding, the number of K15+ cells in UVB-irradiated HA-PE-treated mice was similar 
to controls at 4 weeks, but reduced significantly after 26 weeks of irradiation (Figure 16, 
C). This finding indicates that the adult stem cells were gradually lost due to cell death over 
26 weeks. This apoptosis was associated with suppression of the pro-survival BCL2 
expression in the epidermis and hair follicles (Figure 14). Evasion of apoptosis and 
sustained BCL2 expression are a hallmark of BCC carcinogenesis199,201,216, all of which 
were absent in HA-PE treated group.  
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Previous studies report that the cell of origin in BCC pathogenesis depends on the 
component of sonic hedgehog signaling that is affected. For example, mutational 
inactivation of PTCH1 gives rise to BCCs originating from the K15+ BuSCs in the hair 
follicles. In contrast, constitutive activation of SMO or GLI2 produce BCCs arising from 
the K14+ adult stem cells in the interfollicular epidermis. Interestingly, BCCs arising from 
different epidermal compartments exhibit unique histopathological characteristics, which 
can be used to provide clues of the cell of origin when studying these keratinocyte tumors. 
Therefore, to investigate the epidermal compartment and the identity of cancer-initiating 
cells, I examined the histopathological characteristics of macroscopic BCC tumors as 
described previously58,62. The BCC tumors in Ptch+/LacZ/Hr-/- mice displayed irregularly 
shaped nests organized in a radiating, branching pattern resembling follicular 
differentiation (Figure 17.A), consistent with previous reports of micronodular BCC 
arising from hair follicles56,58,59. Further, smooth muscle actin (SMA) expression in hair 
follicle cells is suggestive of inappropriate myoepithelial differentiation, a prominent 
feature in sporadic BCC patients and susceptible mice driven by sonic hedgehog activation 
under the K15 promoter58. Interestingly, strong intracytoplasmic SMA reactivity was 
observed in BCC tumors (Figure 17.B) and the tumor-adjacent hair follicles (Figure 17. C), 
but was absent from the tumor-adjacent interfollicular epidermis, thus predicting a 
connection between BCCs in Ptch+/LacZ/Hr-/- mice and hair follicles. Further, rare initial 
phases of neoplasm development demonstrated a direct association with the hair follicles 
(Figure 17.D). Strong K15 expression was detected in peripheral cells of developed tumor 
nests (Figure 17.E) and at early stages of atypical outgrowth from the bulge (Figure 17.C), 
thus predictive of BCCs arising from the hair follicles. This is supported by previous 
studies reporting prominent K15 immunoreactivity in human nodular BCCs, a subtype 
commonly associated with the bulge204,217. Taken together, the findings here predict the 
macroscopic BCC tumors likely arise from the K15-expressing stem cells in hair follicles 
in Ptch+/LacZ/Hr-/- mice.  
Since cancer-initiating cells rely on sonic hedgehog signaling to drive BCC tumorigenesis, 
the loss of the oncogenic driver triggers apoptosis in pre-malignant cells. Previous in vivo 
and cell culture studies show the depletion of sonic hedgehog by an inhibitor (cyclopamine) 
leads to adult stem cell quiescence and apoptosis46,47. In this study, sonic hedgehog 
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signaling in the bulge and ORS was reduced by HA-PE application, which coincided with 
enhanced apoptosis in K15+ adult stem cells that rely on sonic hedgehog hyperactivation 
for tumorigenesis. Further, the data in this study demonstrated the activating ligand mRNA 
expression, SHH, was inhibited by HA-PE application (Figure 6.C), suggesting signaling 
inhibition occurs at the PTCH receptor level. In this context, CD44 is a promising candidate 
of signal transduction mediated by HA binding. CD44 is a well-established HA receptor 
that regulates downstream pathways, such as Wnt/beta-catenin218,219, that modulate SHH 
transcription220–222. Further, signaling downstream of CD44 is dependent on the identity of 
CD44 variant132,134,223, thus adding an additional layer of complexity. Therefore, future 
experiments should be conducted to elucidate the mechanism underlying HMW-HA-
mediated inhibition of sonic hedgehog activation and the role of CD44.  
4.4 Future directions 
Causation of HA-PE application and sonic hedgehog suppression should be established in 
future experiments. K15+ cells isolated from Ptch+/- mice will be irradiated and treated with 
HA-PE. It is expected that HA-PE will reduce sonic hedgehog activation, restrict 
proliferation, and promote apoptosis. Since HA-PE reduced SHH transcription, an 
activating ligand that is not a hedgehog target gene, we speculate that pathway inhibition 
occurs at the Shh/PTCH1 level. Therefore, the addition of a downstream activator, such as 
an SMO agonist, is expected to override the effects of HA-PE in K15+ cells. Further, we 
speculate that this HA suppression of BCC initiation is orchestrated by CD44 in the hair 
follicles. To that end, CD44 standard- and variant-specific antibodies that interfere with 
HA-binding should be added to the Ptch1+/- K15+ cells as additional controls, and examined 
to assess whether HA-mediated suppression is conducted through CD44 binding. It is 
expected that interference with CD44/HA interaction will abolish the suppressive effect of 
HA-PE on sonic hedgehog signaling and proliferation. Since dysregulated proliferation, 
survival and inappropriate differentiation of damage-sustaining cells in hair follicles were 
detected in this study, mutational analyses should also be conducted on skin biopsies to 
examine alterations in additional driver pathways that regulate proliferation, stem cell 
survival and differentiation, such as WNT/β-catenin and Notch signaling, in the skin. 
Moreover, mutational analyses will provide data on the identity of the somatic mutations 
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in UVB-exposed susceptible mice, thus allowing us to examine whether HA-PE modifies 
the microenvironment to select for mutations to prevent carcinogenesis. Lastly, RNAseq 
analyses should be performed to provide an unbiased assessment of transcriptome and 
pathway alterations induced by HA-PE application.  
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5 Conclusions  
Taken together, the data presented here suggest a novel mechanism of HA-mediated 
resistance against tumor initiation in the context of BCC carcinogenesis. The accumulation 
of HMW-HA in epidermis did not exert its protective functions through shielding 
epidermal cells from DNA damage. Instead, HA-PE inhibited the tumorigenic potential of 
mutations via restricting proliferation and promoting apoptosis. Specifically, HA-PE 
prevents oncogenic sonic hedgehog signaling in the hair follicles, where the K15+ cancer-
initiating cells reside in the Ptch+/LacZ/Hr-/- model. This chronic loss of oncogenic driver 
signaling limited the proliferative capacity of K15+ BuSCs, and resulted in a gradual 
depletion of cancer-initiating cells via apoptosis. However, this reduction in proliferation 
and enhanced apoptosis did not interfere with homeostasis as indicated by CD44v3 
expression. HA-PE also contributed to establishing proper tissue architecture by 
maintaining a distinctive stratum basale separated from suprabasal layers. Overall, the 
findings here implicate HA-PE as a promising BCC prophylactic that can reduce BCC-
associated healthcare costs and improve quality of life in patients.  Moreover, aberrant 
hedgehog signaling is implicated in cancer stem cell maintenance224,225,226 that is required 
for tumor initiation in the breast, prostate and colon cancer38,227,228. Therefore, a 
mechanistic understanding of HA-PE mediated resistance will have broad applications for 
developing preventative therapies. HA-PE may be re-purposed to reduce the tumorigenic 
potential of at-risk patients, and permit the development of preventative medicines against 
breast, prostate, and colon cancer 38,226,227,228. 
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Appendix A: Supplemental materials  
 
Supplemental Figure 1. HA-PE on CD44 isoform expression. mRNA expression of 
CD44s, v4, v8, v10 were assessed through RT-PCR using primers flanking the variable 
region in CD44, and compared with the housekeeping gene GAPDH. Isoform expression 
of CD44v4, v8, v10 were unchanged by HA-PE application in susceptible mice after 4 
weeks of UVB irradiation. Experiments described in A. and B. were repeated three times.  
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Supplemental Figure 2. K15-expressing bulge stem cells are not lost in disrupted hair 
follicles in Ptch+/LacZ/Hr-/- mice after 4 weeks of irradiation. A. K15 expression (red) in 
hair follicles, and; B. in stratum basale of control and treatment groups. All slides 
counterstained with DAPI (blue). In normal follicles, the outer root sheath extends past the 
bulge region into the hair bulb, and the bulge region is located above the sebaceous gland. 
The hair bulb disintegrates after the first hair cycle in Hr-/- mice, and the bulge region is 
often located at the bottom of the disrupted hair follicle. However, these K15+ stem cells 
are not lost despite the disrupted morphology. Further, K15+ stem cells can migrate into 
stratum basale to participate in interfollicular epidermis renewal. However, no K15+ cells 
in stratum basale were observed in HA-PE treated group.  Histology sections of wildtype 
epidermis are adapted from Blue Histology, University of Western Australia 
(http://www.lab.anhb.uwa.edu.au/mb140/).  Arrowheads indicate the outer root sheath 
(ORS) and bulge region in disrupted and wildtype hair follicles.  
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